Sample	MFP	MFP_updated	Patient	Diagnosis	acronym	TCGA_recombined_cohort	TCGA_all_samples	TCGA_filtered_samples	TCGA_unique_cases	LDT_RNA	LDT_DNA	BG_expressions	BG_sMAF	BG_fusions	BG_CNA	Age	Gender	histological_type	Stage	Stage_Extended	OS	OS_FLAG	PFS	PFS_FLAG	PFI.CDR	PFI_FLAG.CDR	DFI.CDR	DFI_FLAG.CDR	DSS.CDR	DSS_FLAG.CDR	OS.CDR	OS_FLAG.CDR	PFS.CDR	PFS_FLAG.CDR	purity	ploidy	MFP_category
TCGA-3N-A9WB-06	D	2018-06-18	TCGA-3N-A9WB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	71.0	M	Metastatic melanoma	I	IA	92.0	1.0			426.0	1.0			518.0	1.0	518.0	1.0	426.0	1.0	0.91	2.24	
TCGA-3N-A9WC-06	B	2018-06-18	TCGA-3N-A9WC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	82.0	M	Metastatic melanoma	II	IIA	378.0	0.0	61.0	1.0	1705.0	1.0			2022.0	0.0	2022.0	0.0	1705.0	1.0	0.58	2.07	
TCGA-3N-A9WD-06	A	2018-06-18	TCGA-3N-A9WD	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	82.0	M	Metastatic melanoma	III	IIIA	212.0	1.0	123.0	1.0	306.0	1.0			395.0	1.0	395.0	1.0	306.0	1.0	0.45	1.96	
TCGA-BF-A1PU-01	D	2018-06-18	TCGA-BF-A1PU	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	46.0	F	Metastatic melanoma	II	IIC	387.0	0.0	484.0	1.0	484.0	1.0			387.0	0.0	387.0	0.0	484.0	1.0	0.92	1.76	
TCGA-BF-A1PV-01	D	2018-06-18	TCGA-BF-A1PV	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	74.0	F	Metastatic melanoma	II	IIC	14.0	0.0	14.0	0.0	14.0	0.0			14.0	0.0	14.0	0.0	14.0	0.0	0.92	2.12	
TCGA-BF-A1PX-01	A	2018-06-18	TCGA-BF-A1PX	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	56.0	M	Metastatic melanoma	III	IIIB	282.0	1.0	282.0	0.0	282.0	0.0			282.0	0.0	282.0	1.0	282.0	1.0	0.25	1.79	
TCGA-BF-A1PZ-01	D	2018-06-18	TCGA-BF-A1PZ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	71.0	F	Metastatic melanoma	II	IIB	853.0	0.0	853.0	0.0	853.0	0.0			853.0	0.0	853.0	0.0	853.0	0.0	0.9	2.15	
TCGA-BF-A1Q0-01	D	2018-06-18	TCGA-BF-A1Q0	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	80.0	M	Metastatic melanoma	II	IIC	831.0	0.0	831.0	0.0	831.0	0.0			831.0	0.0	831.0	0.0	831.0	0.0	0.4	5.61	
TCGA-BF-A3DJ-01	C	2018-06-18	TCGA-BF-A3DJ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	36.0	F	Metastatic melanoma	III	IIIB	464.0	0.0	217.0	1.0	217.0	1.0			464.0	0.0	464.0	0.0	217.0	1.0	0.8	1.86	
TCGA-BF-A3DL-01	D	2018-06-18	TCGA-BF-A3DL	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	84.0	F	Metastatic melanoma	III	IIIB	769.0	0.0	769.0	0.0	769.0	0.0			769.0	0.0	769.0	0.0	769.0	0.0	0.49	3.96	
TCGA-BF-A3DM-01	D	2018-06-18	TCGA-BF-A3DM	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	63.0	M	Metastatic melanoma	II	IIA	601.0	0.0	601.0	0.0	601.0	0.0			601.0	0.0	601.0	0.0	601.0	0.0	0.94	1.93	
TCGA-BF-A3DN-01	C	2018-06-18	TCGA-BF-A3DN	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	81.0	F	Metastatic melanoma	III	IIIC	717.0	0.0	717.0	0.0	717.0	0.0			717.0	0.0	717.0	0.0	717.0	0.0	0.75	2.6	
TCGA-BF-A5EO-01	C	2018-06-18	TCGA-BF-A5EO	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	65.0	M	Metastatic melanoma	II	IIC	703.0	0.0	703.0	0.0	703.0	0.0			703.0	0.0	703.0	0.0	703.0	0.0	0.6	1.9	
TCGA-BF-A5EP-01	D	2018-06-18	TCGA-BF-A5EP	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	75.0	F	Metastatic melanoma	III	IIIC	335.0	0.0	335.0	0.0	335.0	0.0			335.0	0.0	335.0	0.0	335.0	0.0	0.75	3.21	
TCGA-BF-A5EQ-01	A	2018-06-18	TCGA-BF-A5EQ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	63.0	M	Metastatic melanoma	II	IIC	323.0	0.0	323.0	0.0	323.0	0.0			323.0	0.0	323.0	0.0	323.0	0.0	0.58	3.74	
TCGA-BF-A5ER-01	D	2018-06-18	TCGA-BF-A5ER	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	63.0	M	Metastatic melanoma	II	IIC	327.0	0.0	327.0	0.0	327.0	0.0			327.0	0.0	327.0	0.0	327.0	0.0	0.8	2.08	
TCGA-BF-A5ES-01	C	2018-06-18	TCGA-BF-A5ES	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	76.0	F	Metastatic melanoma	II	IIC	490.0	0.0	490.0	0.0	490.0	0.0			490.0	0.0	490.0	0.0	490.0	0.0	0.71	2.07	
TCGA-BF-A9VF-01	D	2018-06-18	TCGA-BF-A9VF	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	77.0	M	Metastatic melanoma	II	IIC	440.0	0.0	440.0	0.0	440.0	0.0			440.0	0.0	440.0	0.0	440.0	0.0	0.95	1.94	
TCGA-BF-AAOU-01	C	2018-06-18	TCGA-BF-AAOU	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	73.0	F	Metastatic melanoma	II	IIC	476.0	0.0	476.0	0.0	476.0	0.0			476.0	0.0	476.0	0.0	476.0	0.0	0.59	1.89	
TCGA-BF-AAOX-01	D	2018-06-18	TCGA-BF-AAOX	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	83.0	M	Metastatic melanoma	II	IIC	444.0	0.0	444.0	0.0	444.0	0.0			444.0	0.0	444.0	0.0	444.0	0.0	0.68	2.03	
TCGA-BF-AAP0-06	B	2018-06-18	TCGA-BF-AAP0	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	40.0	F	Metastatic melanoma	IV	IV	454.0	0.0	454.0	0.0	454.0	0.0			454.0	0.0	454.0	0.0	454.0	0.0	0.25	1.97	
TCGA-BF-AAP1-01	D	2018-06-18	TCGA-BF-AAP1	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	86.0	M	Metastatic melanoma	II	IIC	409.0	0.0	409.0	0.0	409.0	0.0			409.0	0.0	409.0	0.0	409.0	0.0	0.85	3.88	
TCGA-BF-AAP2-01	B	2018-06-18	TCGA-BF-AAP2	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	62.0	M	Metastatic melanoma	II	IIB	405.0	0.0	405.0	0.0	405.0	0.0			405.0	0.0	405.0	0.0	405.0	0.0	0.89	1.91	
TCGA-BF-AAP4-01	B	2018-06-18	TCGA-BF-AAP4	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	61.0	M	Metastatic melanoma	II	IIC	335.0	0.0	335.0	0.0	335.0	0.0			335.0	0.0	335.0	0.0	335.0	0.0	0.42	3.2	
TCGA-BF-AAP6-01	D	2018-06-18	TCGA-BF-AAP6	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	55.0	M	Metastatic melanoma	III	III	325.0	0.0	325.0	0.0	325.0	0.0			325.0	0.0	325.0	0.0	325.0	0.0	0.86	2.08	
TCGA-BF-AAP7-01	A	2018-06-18	TCGA-BF-AAP7	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	76.0	F	Metastatic melanoma	II	IIC	318.0	0.0	318.0	0.0	318.0	0.0			318.0	0.0	318.0	0.0	318.0	0.0	0.41	1.91	
TCGA-BF-AAP8-01	B	2018-06-18	TCGA-BF-AAP8	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	58.0	M	Metastatic melanoma	II	IIC	447.0	0.0	447.0	0.0	447.0	0.0			447.0	0.0	447.0	0.0	447.0	0.0	0.83	2.15	
TCGA-D3-A1Q1-06	D	2018-06-18	TCGA-D3-A1Q1	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	79.0	F	Metastatic melanoma	III	IIIC	501.0	1.0	55.0	1.0	58.0	1.0			504.0	1.0	504.0	1.0	58.0	1.0	0.97	3.3	
TCGA-D3-A1Q4-06	C	2018-06-18	TCGA-D3-A1Q4	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	53.0	F	Metastatic melanoma	III	IIIC	3379.0	0.0	3379.0	0.0	3408.0	0.0			3408.0	0.0	3408.0	0.0	3408.0	0.0	0.52	1.85	
TCGA-D3-A1Q5-06	D	2018-06-18	TCGA-D3-A1Q5	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	60.0	M	Metastatic melanoma	I/II	I/II	986.0	1.0	14.0	1.0	2452.0	1.0			3424.0		3424.0	1.0	2452.0	1.0	0.92	2.86	
TCGA-D3-A1Q6-06	D	2018-06-18	TCGA-D3-A1Q6	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	55.0	M	Metastatic melanoma	III	III	2134.0	1.0			48.0	1.0			2184.0	0.0	2184.0	1.0	48.0	1.0	0.5	3.25	
TCGA-D3-A1Q7-06	A	2018-06-18	TCGA-D3-A1Q7	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	42.0	F	Metastatic melanoma	I	IB	3370.0	0.0	238.0	1.0	921.0	1.0			4053.0	0.0	4053.0	0.0	921.0	1.0	0.38	2.02	
TCGA-D3-A1Q8-06	C	2018-06-18	TCGA-D3-A1Q8	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	33.0	M	Metastatic melanoma	IV	IV	854.0	1.0	147.0	1.0	147.0	1.0			854.0	1.0	854.0	1.0	147.0	1.0	0.53	1.77	
TCGA-D3-A1Q9-06	D	2018-06-18	TCGA-D3-A1Q9	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	72.0	M	Metastatic melanoma	III	IIIB	686.0	1.0			44.0	1.0			961.0	1.0	961.0	1.0	44.0	1.0	0.69	3.37	
TCGA-D3-A1QB-06	B	2018-06-18	TCGA-D3-A1QB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	75.0	F	Metastatic melanoma	III	III	2471.0	0.0			0.0	1.0			2912.0	0.0	2912.0	0.0	0.0	1.0	0.45	2.19	
TCGA-D3-A2J6-06	B	2018-06-18	TCGA-D3-A2J6	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	65.0	M	Metastatic melanoma	II	IIB	313.0	1.0			448.0	1.0			1321.0	1.0	1321.0	1.0	448.0	1.0	0.71	1.82	
TCGA-D3-A2J7-06	A	2018-06-18	TCGA-D3-A2J7	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	67.0	M	Metastatic melanoma	III	IIIC	2595.0	1.0			13.0	1.0			3136.0	1.0	3136.0	1.0	13.0	1.0	0.42	1.81	
TCGA-D3-A2J8-06	A	2018-06-18	TCGA-D3-A2J8	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	48.0	M	Metastatic melanoma	I	IB	255.0	1.0			1737.0	1.0			1992.0	1.0	1992.0	1.0	1737.0	1.0	0.21	2.19	
TCGA-D3-A2J9-06	A	2018-06-18	TCGA-D3-A2J9	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	75.0	M	Metastatic melanoma	III	IIIC	643.0	1.0	151.0	1.0	231.0	1.0			723.0	1.0	723.0	1.0	231.0	1.0	0.2	2.33	
TCGA-D3-A2JA-06	C	2018-06-18	TCGA-D3-A2JA	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	68.0	M	Metastatic melanoma	III	IIIA	2692.0	0.0			40.0	1.0			3514.0	0.0	3514.0	0.0	40.0	1.0	0.5	2.68	
TCGA-D3-A2JB-06	B	2018-06-18	TCGA-D3-A2JB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	70.0	F	Metastatic melanoma	0	0	2075.0	1.0													0.21	1.88	
TCGA-D3-A2JC-06	B	2018-06-18	TCGA-D3-A2JC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	53.0	F	Metastatic melanoma	III	III	2639.0	0.0	2639.0	0.0	2639.0	0.0			2639.0	0.0	2639.0	0.0	2639.0	0.0	0.47	3.09	
TCGA-D3-A2JD-06	D	2018-06-18	TCGA-D3-A2JD	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	58.0	M	Metastatic melanoma	III	IIIC	347.0	1.0	71.0	1.0	85.0	1.0			361.0	1.0	361.0	1.0	85.0	1.0	0.39	3.21	
TCGA-D3-A2JE-06	D	2018-06-18	TCGA-D3-A2JE	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	75.0	F	Metastatic melanoma	III	IIIC	701.0	1.0	9.0	1.0	149.0	1.0			841.0	1.0	841.0	1.0	149.0	1.0	0.79	3.68	
TCGA-D3-A2JG-06	C	2018-06-18	TCGA-D3-A2JG	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	30.0	F	Metastatic melanoma	III	IIIA	228.0	1.0	54.0	1.0	3279.0	1.0			3453.0	1.0	3453.0	1.0	3279.0	1.0	0.8	1.94	
TCGA-D3-A2JH-06	B	2018-06-18	TCGA-D3-A2JH	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	68.0	M	Metastatic melanoma	I	IB	1100.0	0.0	389.0	1.0	569.0	1.0			1280.0	0.0	1280.0	0.0	569.0	1.0	0.28	2.07	
TCGA-D3-A2JK-06	D	2018-06-18	TCGA-D3-A2JK	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	24.0	M	Metastatic melanoma	III	IIIC	192.0	1.0	85.0	1.0	261.0	1.0			368.0	1.0	368.0	1.0	261.0	1.0	0.66	1.9	
TCGA-D3-A2JL-06	B	2018-06-18	TCGA-D3-A2JL	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	43.0	F	Metastatic melanoma	I/II	I/II	2811.0	0.0	230.0	1.0	2638.0	1.0			5219.0	0.0	5219.0	0.0	2638.0	1.0	0.45	3.47	
TCGA-D3-A2JN-06	A	2018-06-18	TCGA-D3-A2JN	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	46.0	F	Metastatic melanoma	III	III	2022.0	1.0	2022.0	0.0	2022.0	0.0			2022.0	0.0	2022.0	1.0	2022.0	1.0	0.33	3.57	
TCGA-D3-A2JO-06	B	2018-06-18	TCGA-D3-A2JO	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	50.0	F	Metastatic melanoma	III	IIIC	1960.0	0.0			50.0	1.0			2010.0	0.0	2010.0	0.0	50.0	1.0	0.33	3.63	
TCGA-D3-A2JP-06	A	2018-06-18	TCGA-D3-A2JP	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	37.0	M	Metastatic melanoma	III	IIIC	1812.0	0.0	227.0	1.0	227.0	1.0			1812.0	0.0	1812.0	0.0	227.0	1.0	0.58	3.24	
TCGA-D3-A3BZ-06	C	2018-06-18	TCGA-D3-A3BZ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	63.0	M	Metastatic melanoma	II	IIB	3488.0	0.0	1852.0	1.0	2340.0	1.0			3976.0	0.0	3976.0	0.0	2340.0	1.0	0.96	2.03	
TCGA-D3-A3C1-06	C	2018-06-18	TCGA-D3-A3C1	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0		M	Metastatic melanoma	I/II	I/II						0.0				0.0		0.0		0.0	0.53	3.26	
TCGA-D3-A3C3-06	D	2018-06-18	TCGA-D3-A3C3	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0		F	Metastatic melanoma	I/II	I/II						0.0				0.0		0.0		0.0	0.57	3.1	
TCGA-D3-A3C6-06	D	2018-06-18	TCGA-D3-A3C6	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	54.0	F	Metastatic melanoma	I	IB	464.0	1.0	139.0	1.0	1441.0	1.0			1766.0	1.0	1766.0	1.0	1441.0	1.0	0.89	1.61	
TCGA-D3-A3C7-06	A	2018-06-18	TCGA-D3-A3C7	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	57.0	F	Metastatic melanoma	III	III	1429.0	0.0	1429.0	0.0	1429.0	0.0			1429.0	0.0	1429.0	0.0	1429.0	0.0	0.79	1.86	
TCGA-D3-A3C8-06	B	2018-06-18	TCGA-D3-A3C8	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	58.0	F	Metastatic melanoma	III	IIIC	1409.0	0.0	55.0	1.0	55.0	1.0			1409.0	0.0	1409.0	0.0	55.0	1.0	0.22	2.0	
TCGA-D3-A3CB-06	A	2018-06-18	TCGA-D3-A3CB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	39.0	M	Metastatic melanoma	I/II	I/II	2503.0	0.0	2503.0	0.0	5065.0	0.0			5065.0	0.0	5065.0	0.0	5065.0	0.0	0.27	2.42	
TCGA-D3-A3CC-06	D	2018-06-18	TCGA-D3-A3CC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	69.0	F	Metastatic melanoma	II	IIC	1867.0	0.0			96.0	1.0			2644.0	0.0	2644.0	0.0	96.0	1.0	0.63	3.42	
TCGA-D3-A3CE-06	A	2018-06-18	TCGA-D3-A3CE	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	74.0	F	Metastatic melanoma	III	III	405.0	1.0			0.0	1.0			1832.0	1.0	1832.0	1.0	0.0	1.0	0.62	3.48	
TCGA-D3-A3CF-06	B	2018-06-18	TCGA-D3-A3CF	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	61.0	F	Metastatic melanoma	III	IIIC	730.0	1.0	113.0	1.0	129.0	1.0			746.0	1.0	746.0	1.0	129.0	1.0	0.22	3.98	
TCGA-D3-A3MO-06	D	2018-06-18	TCGA-D3-A3MO	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	47.0	M	Metastatic melanoma	III	III	284.0	1.0	47.0	1.0	47.0	1.0			284.0	1.0	284.0	1.0	47.0	1.0	0.94	1.87	
TCGA-D3-A3MR-06	B	2018-06-18	TCGA-D3-A3MR	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	42.0	M	Metastatic melanoma	III	III	3151.0	0.0	3108.0	1.0	3108.0	1.0			3151.0	0.0	3151.0	0.0	3108.0	1.0	0.37	1.64	
TCGA-D3-A3MV-06	D	2018-06-18	TCGA-D3-A3MV	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	38.0	F	Metastatic melanoma	III	IIIB	889.0	0.0			16.0	1.0			1378.0	0.0	1378.0	0.0	16.0	1.0	0.74	2.58	
TCGA-D3-A51E-06	B	2018-06-18	TCGA-D3-A51E	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	39.0	F	Metastatic melanoma	I/II	I/II	2835.0	0.0	2835.0	0.0	5318.0	0.0			5318.0	0.0	5318.0	0.0	5318.0	0.0	0.77	2.1	
TCGA-D3-A51F-06	A	2018-06-18	TCGA-D3-A51F	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0		51.0	M	Metastatic melanoma	III	IIIC	1665.0	0.0	1665.0	0.0	1695.0	0.0			1695.0	0.0	1695.0	0.0	1695.0	0.0			
TCGA-D3-A51G-06	D	2018-06-18	TCGA-D3-A51G	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0		M	Metastatic melanoma	0	0															0.76	3.68	
TCGA-D3-A51J-06	B	2018-06-18	TCGA-D3-A51J	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	19.0	M	Metastatic melanoma	III	III	1652.0	0.0			2008.0	1.0			4414.0	0.0	4414.0	0.0	2008.0	1.0	0.55	2.0	
TCGA-D3-A51K-06	B	2018-06-18	TCGA-D3-A51K	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	51.0	M	Metastatic melanoma	III	IIIB	982.0	0.0	982.0	0.0	1002.0	0.0			1002.0	0.0	1002.0	0.0	1002.0	0.0	0.85	2.27	
TCGA-D3-A51N-06	A	2018-06-18	TCGA-D3-A51N	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	56.0	F	Metastatic melanoma	IV	IV	652.0	0.0			18.0	1.0			688.0	0.0	688.0	0.0	18.0	1.0	0.53	3.73	
TCGA-D3-A51R-06	D	2018-06-18	TCGA-D3-A51R	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	60.0	M	Metastatic melanoma	II	IIA	992.0	0.0	67.0	1.0	1016.0	1.0			1941.0	0.0	1941.0	0.0	1016.0	1.0	0.91	2.17	
TCGA-D3-A51T-06	B	2018-06-18	TCGA-D3-A51T	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	59.0	F	Metastatic melanoma	III	IIIC	784.0	0.0	176.0	1.0	210.0	1.0			818.0	0.0	818.0	0.0	210.0	1.0	0.83	1.87	
TCGA-D3-A5GL-06	D	2018-06-18	TCGA-D3-A5GL	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	74.0	M	Metastatic melanoma	I	IB	3353.0	0.0	619.0	1.0	1092.0	1.0			3826.0	0.0	3826.0	0.0	1092.0	1.0	0.78	1.84	
TCGA-D3-A5GN-06	D	2018-06-18	TCGA-D3-A5GN	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	15.0	F	Metastatic melanoma	I	I	1582.0	0.0			1279.0	1.0			4129.0	0.0	4129.0	0.0	1279.0	1.0	0.53	3.99	
TCGA-D3-A5GO-06	D	2018-06-18	TCGA-D3-A5GO	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	61.0	M	Metastatic melanoma	II	II	1456.0	0.0			757.0	1.0			4195.0	0.0	4195.0	0.0	757.0	1.0	0.71	3.76	
TCGA-D3-A5GR-01	C	2018-06-18	TCGA-D3-A5GR	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1						1.0	23.0	F	Metastatic melanoma	III	III	416.0	0.0			0.0	1.0			5424.0	0.0	5424.0	0.0	0.0	1.0	0.45	2.04	
TCGA-D3-A5GR-06	C	2018-06-18	TCGA-D3-A5GR	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0		23.0	F	Metastatic melanoma	III	III	416.0	0.0			0.0	1.0			5424.0	0.0	5424.0	0.0	0.0	1.0			
TCGA-D3-A5GS-06	A	2018-06-18	TCGA-D3-A5GS	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	58.0	M	Metastatic melanoma	IV	IV	539.0	0.0	30.0	1.0	44.0	1.0			553.0	0.0	553.0	0.0	44.0	1.0	0.79	2.05	
TCGA-D3-A5GT-01	D	2018-06-18	TCGA-D3-A5GT	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	43.0	M	Metastatic melanoma	III	IIIC	462.0	0.0	266.0	1.0	291.0	1.0			487.0	0.0	487.0	0.0	291.0	1.0	0.87	4.4	
TCGA-D3-A5GU-06	B	2018-06-18	TCGA-D3-A5GU	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	36.0	M	Metastatic melanoma	I	IB	703.0	0.0			3074.0	1.0			3808.0	0.0	3808.0	0.0	3074.0	1.0	0.73	3.3	
TCGA-D3-A8GB-06	A	2018-06-18	TCGA-D3-A8GB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	48.0	M	Metastatic melanoma	III	IIIB	904.0	1.0	313.0	1.0	347.0	1.0			938.0	1.0	938.0	1.0	347.0	1.0	0.33	1.92	
TCGA-D3-A8GC-06	C	2018-06-18	TCGA-D3-A8GC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	48.0	M	Metastatic melanoma	III	IIIC	671.0	1.0	109.0	1.0	1859.0	1.0			2421.0	1.0	2421.0	1.0	1859.0	1.0	0.81	3.34	
TCGA-D3-A8GD-06	B	2018-06-18	TCGA-D3-A8GD	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	63.0	F	Metastatic melanoma	III	IIIC	676.0	0.0	105.0	1.0	147.0	1.0			718.0	0.0	718.0	0.0	147.0	1.0	0.28	3.07	
TCGA-D3-A8GE-06	A	2018-06-18	TCGA-D3-A8GE	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	26.0	M	Metastatic melanoma	IV	IV	804.0	0.0	59.0	1.0	59.0	1.0			804.0	0.0	804.0	0.0	59.0	1.0	0.6	2.0	
TCGA-D3-A8GI-06	D	2018-06-18	TCGA-D3-A8GI	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	68.0	M	Metastatic melanoma	I	IA	127.0	1.0			50.0	1.0			1780.0	1.0	1780.0	1.0	50.0	1.0	0.79	3.51	
TCGA-D3-A8GJ-06	B	2018-06-18	TCGA-D3-A8GJ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	18.0	M	Metastatic melanoma	II	II	4710.0	0.0			1443.0	1.0			7342.0	0.0	7342.0	0.0	1443.0	1.0	0.45	2.13	
TCGA-D3-A8GK-06	D	2018-06-18	TCGA-D3-A8GK	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	45.0	M	Metastatic melanoma	II	IIA	3309.0	0.0			1555.0	1.0			5177.0	0.0	5177.0	0.0	1555.0	1.0	0.93	2.13	
TCGA-D3-A8GL-06	D	2018-06-18	TCGA-D3-A8GL	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	43.0	M	Metastatic melanoma	III	IIIB	1184.0	1.0			1333.0	1.0			2711.0	1.0	2711.0	1.0	1333.0	1.0	0.95	2.06	
TCGA-D3-A8GM-06	B	2018-06-18	TCGA-D3-A8GM	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	73.0	M	Metastatic melanoma	II	IIB	2663.0	1.0	2663.0	0.0	3259.0	0.0			3259.0	0.0	3259.0	1.0	3259.0	1.0	0.54	3.62	
TCGA-D3-A8GN-06	A	2018-06-18	TCGA-D3-A8GN	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	27.0	F	Metastatic melanoma	I/II	I/II	3786.0	0.0			787.0	1.0			4897.0	0.0	4897.0	0.0	787.0	1.0	0.26	3.68	
TCGA-D3-A8GO-06	A	2018-06-18	TCGA-D3-A8GO	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0		F	Metastatic melanoma	I/II	I/II						1.0				1.0		1.0		1.0	0.37	3.45	
TCGA-D3-A8GP-06	D	2018-06-18	TCGA-D3-A8GP	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	77.0	M	Metastatic melanoma	III	III	3120.0	0.0			535.0	1.0			4646.0	0.0	4646.0	0.0	535.0	1.0	0.96	3.14	
TCGA-D3-A8GQ-06	D	2018-06-18	TCGA-D3-A8GQ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	66.0	M	Metastatic melanoma	II	II	348.0	1.0	42.0	1.0	578.0	1.0			884.0	1.0	884.0	1.0	578.0	1.0	0.63	2.36	
TCGA-D3-A8GR-06	D	2018-06-18	TCGA-D3-A8GR	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	54.0	F	Metastatic melanoma	0	0	169.0	1.0													0.8	1.95	
TCGA-D3-A8GS-06	B	2018-06-18	TCGA-D3-A8GS	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	52.0	M	Metastatic melanoma	I	I	732.0	1.0			2641.0	1.0			3564.0	1.0	3564.0	1.0	2641.0	1.0	0.53	1.8	
TCGA-D3-A8GV-06	D	2018-06-18	TCGA-D3-A8GV	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	25.0	M	Metastatic melanoma	I/II	I/II	619.0	1.0			3896.0	1.0			5101.0	1.0	5101.0	1.0	3896.0	1.0	0.94	1.99	
TCGA-D9-A149-06	B	2018-06-18	TCGA-D9-A149	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	65.0	F	Metastatic melanoma			1663.0	0.0			1290.0	1.0			1663.0	0.0	1663.0	0.0	1290.0	1.0	0.57	3.76	
TCGA-D9-A1JW-06	B	2018-06-18	TCGA-D9-A1JW	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	82.0	M	Metastatic melanoma			111.0	0.0			10.0	1.0			111.0	0.0	111.0	0.0	10.0	1.0	0.56	2.21	
TCGA-D9-A1JX-06	B	2018-06-18	TCGA-D9-A1JX	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	80.0	F	Metastatic melanoma			216.0	1.0			195.0	1.0			216.0	1.0	216.0	1.0	195.0	1.0	0.8	1.96	
TCGA-D9-A1X3-01	D	2018-06-18	TCGA-D9-A1X3	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1						1.0	63.0	M	Metastatic melanoma			551.0	0.0			551.0	0.0			551.0	0.0	551.0	0.0	551.0	0.0	0.97	1.94	
TCGA-D9-A1X3-06	D	2018-06-18	TCGA-D9-A1X3	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0		63.0	M	Metastatic melanoma			551.0	0.0			551.0	0.0			551.0	0.0	551.0	0.0	551.0	0.0			
TCGA-D9-A3Z1-06	B	2018-06-18	TCGA-D9-A3Z1	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	66.0	M	Metastatic melanoma	III	IIIC	245.0	1.0	112.0	1.0	335.0	1.0			468.0	1.0	468.0	1.0	335.0	1.0	0.33	2.02	
TCGA-D9-A3Z3-06	B	2018-06-18	TCGA-D9-A3Z3	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	39.0	F	Metastatic melanoma	III	IIIB	667.0	0.0	667.0	0.0	678.0	0.0			678.0	0.0	678.0	0.0	678.0	0.0	0.61	1.82	
TCGA-D9-A3Z4-01	A	2018-06-18	TCGA-D9-A3Z4	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	54.0	M	Metastatic melanoma	III	IIIC	519.0	1.0	192.0	1.0	192.0	1.0			519.0	1.0	519.0	1.0	192.0	1.0	0.68	3.98	
TCGA-D9-A4Z3-01	C	2018-06-18	TCGA-D9-A4Z3	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	73.0	F	Metastatic melanoma	III	IIIC	505.0	0.0	100.0	1.0	100.0	1.0			505.0	0.0	505.0	0.0	100.0	1.0	0.86	2.13	
TCGA-D9-A4Z5-01	C	2018-06-18	TCGA-D9-A4Z5	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	68.0	M	Metastatic melanoma	II	IIB	218.0	0.0	218.0	0.0	218.0	0.0			218.0	0.0	218.0	0.0	218.0	0.0	0.93	3.48	
TCGA-D9-A4Z6-06	D	2018-06-18	TCGA-D9-A4Z6	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0		54.0	M	Metastatic melanoma	III	IIIC	397.0	1.0	49.0	1.0	213.0	1.0			561.0	1.0	561.0	1.0	213.0	1.0			
TCGA-D9-A6E9-06	B	2018-06-18	TCGA-D9-A6E9	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	75.0	F	Metastatic melanoma	III	IIIA	301.0	0.0	301.0	0.0	301.0	0.0			301.0	0.0	301.0	0.0	301.0	0.0	0.37	3.29	
TCGA-D9-A6EA-06	D	2018-06-18	TCGA-D9-A6EA	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	70.0	M	Metastatic melanoma	III	IIIC	344.0	0.0	344.0	0.0	766.0	0.0			766.0	0.0	766.0	0.0	766.0	0.0	0.85	4.57	
TCGA-D9-A6EC-06	B	2018-06-18	TCGA-D9-A6EC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	56.0	M	Metastatic melanoma	III	IIIA	746.0	0.0	746.0	0.0	2359.0	0.0			2359.0	0.0	2359.0	0.0	2359.0	0.0	0.95	3.33	
TCGA-D9-A6EG-06	D	2018-06-18	TCGA-D9-A6EG	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	56.0	M	Metastatic melanoma	III	IIIA	444.0	1.0	144.0	1.0	398.0	1.0			698.0		698.0	1.0	398.0	1.0	0.84	2.08	
TCGA-DA-A1HV-06	B	2018-06-18	TCGA-DA-A1HV	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	75.0	F	Metastatic melanoma	III	IIIB	2326.0	0.0	863.0	1.0	866.0	1.0			2329.0	0.0	2329.0	0.0	866.0	1.0	0.67	2.92	
TCGA-DA-A1HW-06	B	2018-06-18	TCGA-DA-A1HW	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	37.0	F	Metastatic melanoma	III	IIIB	1089.0	1.0	845.0	1.0	852.0	1.0			820.0	0.0	820.0	0.0	852.0	1.0	0.67	1.63	
TCGA-DA-A1HY-06	C	2018-06-18	TCGA-DA-A1HY	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	42.0	M	Metastatic melanoma	III	III	2397.0	0.0	2397.0	0.0	4407.0	0.0			4407.0	0.0	4407.0	0.0	4407.0	0.0	0.76	2.0	
TCGA-DA-A1I0-06	A	2018-06-18	TCGA-DA-A1I0	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	63.0	M	Metastatic melanoma	IV	IV	431.0	1.0	410.0	1.0	599.0	1.0			620.0	1.0	620.0	1.0	599.0	1.0	0.47	2.23	
TCGA-DA-A1I1-06	A	2018-06-18	TCGA-DA-A1I1	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	55.0	M	Metastatic melanoma	III	III	2034.0	0.0	857.0	1.0	5591.0	1.0			6768.0	0.0	6768.0	0.0	5591.0	1.0	0.56	2.97	
TCGA-DA-A1I2-06	A	2018-06-18	TCGA-DA-A1I2	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	45.0	M	Metastatic melanoma	III	III	691.0	1.0			4679.0	1.0			5370.0	1.0	5370.0	1.0	4679.0	1.0	0.77	2.86	
TCGA-DA-A1I4-06	C	2018-06-18	TCGA-DA-A1I4	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	51.0	M	Metastatic melanoma	III	IIIC	304.0	1.0	100.0	1.0	889.0	1.0			1093.0	1.0	1093.0	1.0	889.0	1.0	0.5	2.01	
TCGA-DA-A1I5-06	C	2018-06-18	TCGA-DA-A1I5	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	27.0	F	Metastatic melanoma	IV	IV	2196.0	0.0	2196.0	0.0	4107.0	0.0			4107.0	0.0	4107.0	0.0	4107.0	0.0	0.56	1.84	
TCGA-DA-A1I7-06	C	2018-06-18	TCGA-DA-A1I7	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	62.0	M	Metastatic melanoma	III	IIIB	1958.0	0.0	10.0	1.0	755.0	1.0			2703.0	0.0	2703.0	0.0	755.0	1.0	0.58	3.12	
TCGA-DA-A1I8-06	C	2018-06-18	TCGA-DA-A1I8	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	63.0	F	Metastatic melanoma	II	IIC	765.0	1.0	86.0	1.0	961.0	1.0			1640.0	1.0	1640.0	1.0	961.0	1.0	0.67	4.47	
TCGA-DA-A1IA-06	D	2018-06-18	TCGA-DA-A1IA	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	32.0	F	Metastatic melanoma	III	IIIB	150.0	1.0	150.0	1.0	2005.0	1.0			2005.0	1.0	2005.0	1.0	2005.0	1.0	0.94	3.19	
TCGA-DA-A1IB-06	B	2018-06-18	TCGA-DA-A1IB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	69.0	F	Metastatic melanoma	III	IIIC	1202.0	1.0	210.0	1.0	243.0	1.0			825.0	0.0	825.0	0.0	243.0	1.0	0.18	2.08	
TCGA-DA-A1IC-06	D	2018-06-18	TCGA-DA-A1IC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	81.0	M	Metastatic melanoma	III	IIIB	202.0	1.0	61.0	1.0	1930.0	1.0			2071.0	1.0	2071.0	1.0	1930.0	1.0	0.77	2.11	
TCGA-DA-A3F2-06	A	2018-06-18	TCGA-DA-A3F2	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1					0.0	1.0	55.0	M	Metastatic melanoma	III	IIIB	751.0	1.0	149.0	1.0	430.0	1.0			1032.0	1.0	1032.0	1.0	430.0	1.0	0.93	2.0	
TCGA-DA-A3F3-06	D	2018-06-18	TCGA-DA-A3F3	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	52.0	M	Metastatic melanoma	III	IIIB	213.0	1.0	213.0	1.0	319.0	1.0			319.0	1.0	319.0	1.0	319.0	1.0	0.92	2.46	
TCGA-DA-A3F5-06	D	2018-06-18	TCGA-DA-A3F5	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	45.0	M	Metastatic melanoma	I	I	854.0	1.0	822.0	1.0	6841.0	1.0			6873.0	1.0	6873.0	1.0	6841.0	1.0	0.44	3.98	
TCGA-DA-A3F8-06	B	2018-06-18	TCGA-DA-A3F8	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	39.0	M	Metastatic melanoma	III	IIIB	1293.0	0.0	1293.0	0.0	1319.0	0.0			1319.0	0.0	1319.0	0.0	1319.0	0.0	0.39	2.08	
TCGA-DA-A95V-06	B	2018-06-18	TCGA-DA-A95V	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	83.0	F	Metastatic melanoma	II	IIC	1139.0	0.0	1139.0	0.0	2193.0	0.0			2193.0	0.0	2193.0	0.0	2193.0	0.0	0.55	4.2	
TCGA-DA-A95W-06	D	2018-06-18	TCGA-DA-A95W	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	52.0	M	Metastatic melanoma	III	IIIB	1136.0	0.0	1136.0	0.0	1136.0	0.0			1136.0	0.0	1136.0	0.0	1136.0	0.0	0.88	2.17	
TCGA-DA-A95X-06	C	2018-06-18	TCGA-DA-A95X	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	62.0	M	Metastatic melanoma	I	IB	1136.0	0.0	1136.0	0.0	2249.0	0.0			2249.0	0.0	2249.0	0.0	2249.0	0.0	0.87	1.76	
TCGA-DA-A95Y-06	D	2018-06-18	TCGA-DA-A95Y	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	68.0	M	Metastatic melanoma	II	IIC	159.0	1.0	67.0	1.0	338.0	1.0			430.0	1.0	430.0	1.0	338.0	1.0	0.75	3.87	
TCGA-DA-A95Z-06	D	2018-06-18	TCGA-DA-A95Z	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	87.0	M	Metastatic melanoma	IV	IV	396.0	0.0	396.0	0.0	396.0	0.0			396.0	0.0	396.0	0.0	396.0	0.0	0.8	3.47	
TCGA-DA-A960-01	D	2018-06-18	TCGA-DA-A960	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	73.0	M	Metastatic melanoma	II	IIB	408.0	0.0	408.0	0.0	804.0	0.0			804.0	0.0	804.0	0.0	804.0	0.0	0.85	3.61	
TCGA-EB-A1NK-01	C	2018-06-18	TCGA-EB-A1NK	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	48.0	M	Metastatic melanoma	II	IIC	1039.0	0.0	1039.0	0.0	1039.0	0.0			1039.0	0.0	1039.0	0.0	1039.0	0.0	0.65	2.05	
TCGA-EB-A24C-01	C	2018-06-18	TCGA-EB-A24C	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	56.0	M	Metastatic melanoma			632.0	0.0	465.0	1.0	465.0	1.0			632.0	0.0	632.0	0.0	465.0	1.0	0.91	1.72	
TCGA-EB-A24D-01	D	2018-06-18	TCGA-EB-A24D	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	72.0	M	Metastatic melanoma	III	IIIB	645.0	0.0	500.0	1.0	500.0	1.0			645.0	0.0	645.0	0.0	500.0	1.0	0.79	3.67	
TCGA-EB-A299-01	C	2018-06-18	TCGA-EB-A299	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	63.0	M	Metastatic melanoma	II	IIA	378.0	0.0	378.0	0.0	378.0	0.0			378.0	0.0	378.0	0.0	378.0	0.0	0.7	2.01	
TCGA-EB-A3HV-01	C	2018-06-18	TCGA-EB-A3HV	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	37.0	M	Metastatic melanoma	II	IIC	39.0	0.0	39.0	0.0	39.0	0.0			39.0	0.0	39.0	0.0	39.0	0.0	0.75	1.89	
TCGA-EB-A3XB-01	D	2018-06-18	TCGA-EB-A3XB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	63.0	M	Metastatic melanoma	II	II	796.0	0.0	796.0	0.0	796.0	0.0			796.0	0.0	796.0	0.0	796.0	0.0	0.41	3.6	
TCGA-EB-A3XC-01	D	2018-06-18	TCGA-EB-A3XC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	74.0	M	Metastatic melanoma	II	IIC	650.0	0.0	74.0	1.0	74.0	1.0			650.0	0.0	650.0	0.0	74.0	1.0	0.61	3.56	
TCGA-EB-A3XD-01	A	2018-06-18	TCGA-EB-A3XD	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	53.0	F	Metastatic melanoma	II	IIC	1160.0	0.0	1160.0	0.0	1160.0	0.0			1160.0	0.0	1160.0	0.0	1160.0	0.0	0.19	1.97	
TCGA-EB-A3XE-01	A	2018-06-18	TCGA-EB-A3XE	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	77.0	F	Metastatic melanoma	II	IIA	180.0	0.0	180.0	0.0	180.0	0.0			180.0	0.0	180.0	0.0	180.0	0.0	0.63	1.96	
TCGA-EB-A3XF-01	C	2018-06-18	TCGA-EB-A3XF	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	57.0	M	Metastatic melanoma	II	IIC	278.0	0.0	278.0	0.0	278.0	0.0			278.0	0.0	278.0	0.0	278.0	0.0	0.78	2.02	
TCGA-EB-A3Y6-01	D	2018-06-18	TCGA-EB-A3Y6	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	56.0	F	Metastatic melanoma	II	IIC	126.0	0.0	126.0	0.0	126.0	0.0			126.0	0.0	126.0	0.0	126.0	0.0	0.67	1.83	
TCGA-EB-A3Y7-01	D	2018-06-18	TCGA-EB-A3Y7	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	86.0	F	Metastatic melanoma	III	IIIB	326.0	1.0	326.0	0.0	326.0	0.0			326.0	0.0	326.0	1.0	326.0	1.0	0.59	1.92	
TCGA-EB-A41A-01	D	2018-06-18	TCGA-EB-A41A	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	90.0	M	Metastatic melanoma	II	IIC	262.0	0.0	262.0	0.0	262.0	0.0			262.0	0.0	262.0	0.0	262.0	0.0	0.91	2.08	
TCGA-EB-A41B-01	B	2018-06-18	TCGA-EB-A41B	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	76.0	F	Metastatic melanoma	II	IIC	291.0	0.0	291.0	0.0	291.0	0.0			291.0	0.0	291.0	0.0	291.0	0.0	0.88	1.92	
TCGA-EB-A42Y-01	D	2018-06-18	TCGA-EB-A42Y	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	73.0	F	Metastatic melanoma	II	IIC	721.0	1.0	721.0	1.0	721.0	1.0			721.0	1.0	721.0	1.0	721.0	1.0	0.89	2.1	
TCGA-EB-A42Z-01	D	2018-06-18	TCGA-EB-A42Z	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	49.0	M	Metastatic melanoma	III	IIIC	441.0	0.0	441.0	0.0	441.0	0.0			441.0	0.0	441.0	0.0	441.0	0.0	0.89	1.9	
TCGA-EB-A430-01	B	2018-06-18	TCGA-EB-A430	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	83.0	M	Metastatic melanoma	II	IIC					0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.72	1.9	
TCGA-EB-A431-01	D	2018-06-18	TCGA-EB-A431	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	34.0	M	Metastatic melanoma	II	IIC	568.0	0.0	568.0	0.0	568.0	0.0			568.0	0.0	568.0	0.0	568.0	0.0	0.65	2.73	
TCGA-EB-A44N-01	D	2018-06-18	TCGA-EB-A44N	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	59.0	M	Metastatic melanoma	II	IIC	205.0	1.0	115.0	1.0	115.0	1.0			205.0	1.0	205.0	1.0	115.0	1.0	0.94	2.0	
TCGA-EB-A44O-01	D	2018-06-18	TCGA-EB-A44O	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	69.0	M	Metastatic melanoma	II	IIB	81.0	0.0	60.0	1.0	60.0	1.0			81.0	0.0	81.0	0.0	60.0	1.0	0.8	1.77	
TCGA-EB-A44P-01	C	2018-06-18	TCGA-EB-A44P	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	58.0	F	Metastatic melanoma	II	IIC	741.0	0.0	741.0	0.0	741.0	0.0			741.0	0.0	741.0	0.0	741.0	0.0	0.8	1.9	
TCGA-EB-A44Q-06	B	2018-06-18	TCGA-EB-A44Q	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	51.0	F	Metastatic melanoma	III	IIIC	400.0	0.0	400.0	0.0	422.0	0.0			422.0	0.0	422.0	0.0	422.0	0.0	0.64	2.16	
TCGA-EB-A44R-06	B	2018-06-18	TCGA-EB-A44R	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	52.0	M	Metastatic melanoma	III	IIIB	12.0	1.0	12.0	0.0	315.0	0.0			315.0	0.0	315.0	1.0	315.0	1.0	0.57	3.76	
TCGA-EB-A4IQ-01	D	2018-06-18	TCGA-EB-A4IQ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	42.0	F	Metastatic melanoma	III	IIIB	636.0	1.0	337.0	1.0	337.0	1.0			636.0	0.0	636.0	1.0	337.0	1.0	0.51	3.37	
TCGA-EB-A4IS-01	B	2018-06-18	TCGA-EB-A4IS	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	77.0	M	Metastatic melanoma	II	IIB	774.0	0.0	774.0	0.0	774.0	0.0			774.0	0.0	774.0	0.0	774.0	0.0	0.36	3.37	
TCGA-EB-A4OY-01	B	2018-06-18	TCGA-EB-A4OY	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	65.0	F	Metastatic melanoma	III	IIIB	979.0	0.0	979.0	0.0	977.0	0.0			977.0	0.0	977.0	0.0	977.0	0.0	0.58	3.06	
TCGA-EB-A4OZ-01	B	2018-06-18	TCGA-EB-A4OZ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	41.0	F	Metastatic melanoma	III	IIIC	620.0	0.0	620.0	0.0	620.0	0.0			620.0	0.0	620.0	0.0	620.0	0.0	0.23	1.87	
TCGA-EB-A4P0-01	A	2018-06-18	TCGA-EB-A4P0	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	82.0	M	Metastatic melanoma	II	IIC	326.0	1.0	326.0	0.0	326.0	0.0			326.0	0.0	326.0	1.0	326.0	1.0	0.8	3.37	
TCGA-EB-A4XL-01	A	2018-06-18	TCGA-EB-A4XL	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	56.0	F	Metastatic melanoma	II	IIC	777.0	0.0	777.0	0.0	777.0	0.0			777.0	0.0	777.0	0.0	777.0	0.0	0.7	3.69	
TCGA-EB-A51B-01	B	2018-06-18	TCGA-EB-A51B	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	53.0	M	Metastatic melanoma	II	IIC	931.0	0.0	931.0	0.0	931.0	0.0			931.0	0.0	931.0	0.0	931.0	0.0	0.74	3.48	
TCGA-EB-A550-01	C	2018-06-18	TCGA-EB-A550	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	75.0	F	Metastatic melanoma	II	IIC	264.0	1.0	264.0	0.0	264.0	0.0			264.0	0.0	264.0	1.0	264.0	1.0	0.48	1.87	
TCGA-EB-A551-01	B	2018-06-18	TCGA-EB-A551	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	78.0	F	Metastatic melanoma	III	IIIC	590.0	0.0	590.0	0.0	590.0	0.0			590.0	0.0	590.0	0.0	590.0	0.0	0.46	1.75	
TCGA-EB-A553-01	D	2018-06-18	TCGA-EB-A553	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	62.0	M	Metastatic melanoma	II	IIC	226.0	0.0	226.0	0.0	226.0	0.0			226.0	0.0	226.0	0.0	226.0	0.0	0.58	2.68	
TCGA-EB-A57M-01	C	2018-06-18	TCGA-EB-A57M	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	56.0	M	Metastatic melanoma	III	IIIB	472.0	1.0	472.0	0.0	472.0	0.0			472.0	0.0	472.0	1.0	472.0	1.0	0.66	2.19	
TCGA-EB-A5FP-01	D	2018-06-18	TCGA-EB-A5FP	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	65.0	F	Metastatic melanoma	IV	IV	443.0	1.0	13.0	1.0	24.0	1.0			454.0	1.0	454.0	1.0	24.0	1.0	0.77	3.71	
TCGA-EB-A5KH-06	D	2018-06-18	TCGA-EB-A5KH	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	55.0	M	Metastatic melanoma	III	III	80.0	1.0	80.0	0.0	619.0	0.0			619.0	0.0	619.0	1.0	619.0	1.0	0.9	2.22	
TCGA-EB-A5SE-01	D	2018-06-18	TCGA-EB-A5SE	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	73.0	M	Metastatic melanoma	II	IIB	401.0	1.0	367.0	1.0	367.0	1.0			401.0	1.0	401.0	1.0	367.0	1.0	0.89	2.0	
TCGA-EB-A5SF-01	D	2018-06-18	TCGA-EB-A5SF	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1		FF_WES		1.0	1.0	1.0	78.0	F	Metastatic melanoma	II	IIC	369.0	1.0	369.0	0.0	369.0	0.0			369.0	0.0	369.0	1.0	369.0	1.0	0.61	1.74	
TCGA-EB-A5SG-06	B	2018-06-18	TCGA-EB-A5SG	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	57.0	F	Metastatic melanoma			704.0	0.0			1372.0	1.0			2076.0	0.0	2076.0	0.0	1372.0	1.0	0.23	1.94	
TCGA-EB-A5SH-06	D	2018-06-18	TCGA-EB-A5SH	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	60.0	F	Metastatic melanoma	III	III	578.0	0.0			1065.0	1.0			1643.0	0.0	1643.0	0.0	1065.0	1.0	0.73	3.33	
TCGA-EB-A5UL-06	B	2018-06-18	TCGA-EB-A5UL	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	71.0	M	Metastatic melanoma	III	III	771.0	0.0	771.0	0.0	891.0	0.0			891.0	0.0	891.0	0.0	891.0	0.0	0.46	2.75	
TCGA-EB-A5UM-01	B	2018-06-18	TCGA-EB-A5UM	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	48.0	F	Metastatic melanoma	II	IIC	779.0	0.0	779.0	0.0	779.0	0.0			779.0	0.0	779.0	0.0	779.0	0.0	0.72	1.95	
TCGA-EB-A5UN-06	C	2018-06-18	TCGA-EB-A5UN	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	49.0	M	Metastatic melanoma	II	IIC	612.0	0.0	509.0	1.0	1689.0	1.0			1792.0	0.0	1792.0	0.0	1689.0	1.0	0.44	1.92	
TCGA-EB-A5VU-01	D	2018-06-18	TCGA-EB-A5VU	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	56.0	M	Metastatic melanoma	III	IIIB	313.0	1.0	209.0	1.0	217.0	1.0			321.0	1.0	321.0	1.0	217.0	1.0	0.64	3.41	
TCGA-EB-A5VV-06	A	2018-06-18	TCGA-EB-A5VV	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded		1.0		0.0	1.0	74.0	F	Metastatic melanoma	III	IIIB	16.0	0.0	16.0	0.0	214.0	0.0			214.0	0.0	214.0	0.0	214.0	0.0	0.36	2.0	
TCGA-EB-A6L9-06	A	2018-06-18	TCGA-EB-A6L9	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	55.0	M	Metastatic melanoma	III	IIIC	744.0	0.0	744.0	0.0	1109.0	0.0			1109.0	0.0	1109.0	0.0	1109.0	0.0	0.12	3.08	
TCGA-EB-A6QY-01	D	2018-06-18	TCGA-EB-A6QY	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	71.0	M	Metastatic melanoma	II	IIC	382.0	0.0	36.0	1.0	36.0	1.0			382.0	0.0	382.0	0.0	36.0	1.0	0.42	3.21	
TCGA-EB-A6QZ-01	D	2018-06-18	TCGA-EB-A6QZ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	76.0	F	Metastatic melanoma	II	IIA	352.0	1.0	129.0	1.0	129.0	1.0			352.0	1.0	352.0	1.0	129.0	1.0	0.9	1.76	
TCGA-EB-A6R0-01	B	2018-06-18	TCGA-EB-A6R0	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	58.0	F	Metastatic melanoma	II	IIC	608.0	1.0	608.0	0.0	608.0	0.0			608.0	0.0	608.0	1.0	608.0	1.0	0.64	3.76	
TCGA-EB-A82B-01	C	2018-06-18	TCGA-EB-A82B	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	58.0	F	Metastatic melanoma	III	III	380.0	0.0	380.0	0.0	390.0	0.0			390.0	0.0	390.0	0.0	390.0	0.0	0.46	3.5	
TCGA-EB-A82C-01	D	2018-06-18	TCGA-EB-A82C	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	70.0	F	Metastatic melanoma	II	IIC	4.0	0.0	4.0	0.0	17.0	0.0			17.0	0.0	17.0	0.0	17.0	0.0	0.84	3.12	
TCGA-EB-A85I-01	B	2018-06-18	TCGA-EB-A85I	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	66.0	M	Metastatic melanoma	II	IIC	362.0	0.0	362.0	0.0	362.0	0.0			362.0	0.0	362.0	0.0	362.0	0.0	0.52	1.94	
TCGA-EB-A85J-01	B	2018-06-18	TCGA-EB-A85J	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	66.0	F	Metastatic melanoma	II	IIB	360.0	0.0	138.0	1.0	138.0	1.0			360.0	0.0	360.0	0.0	138.0	1.0	0.55	2.11	
TCGA-EB-A97M-01	B	2018-06-18	TCGA-EB-A97M	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	66.0	M	Metastatic melanoma	II	IIC	414.0	0.0	414.0	0.0	414.0	0.0			414.0	0.0	414.0	0.0	414.0	0.0	0.78	3.73	
TCGA-EE-A17X-06	D	2018-06-18	TCGA-EE-A17X	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	54.0	M	Metastatic melanoma	I	IA	352.0	1.0			531.0	1.0			907.0	1.0	907.0	1.0	531.0	1.0	0.93	1.92	
TCGA-EE-A17Y-06	D	2018-06-18	TCGA-EE-A17Y	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	69.0	M	Metastatic melanoma	III	IIIB	321.0	1.0			317.0	1.0			828.0	1.0	828.0	1.0	317.0	1.0	0.54	3.08	
TCGA-EE-A17Z-06	D	2018-06-18	TCGA-EE-A17Z	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	57.0	M	Metastatic melanoma	II	IIB	192.0	1.0	67.0	1.0	138.0	1.0			263.0	1.0	263.0	1.0	138.0	1.0	0.99	1.98	
TCGA-EE-A180-06	D	2018-06-18	TCGA-EE-A180	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0		1.0	69.0	M	Metastatic melanoma	III	III	247.0	1.0			850.0	1.0			2889.0	1.0	2889.0	1.0	850.0	1.0	0.92	2.64	
TCGA-EE-A181-06	B	2018-06-18	TCGA-EE-A181	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	82.0	F	Metastatic melanoma	II	II	34.0	1.0			788.0	1.0			1026.0	0.0	1026.0	1.0	788.0	1.0	0.54	3.07	
TCGA-EE-A182-06	D	2018-06-18	TCGA-EE-A182	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	84.0	F	Metastatic melanoma	III	IIIC	41.0	1.0			270.0	1.0			447.0	1.0	447.0	1.0	270.0	1.0	0.62	1.97	
TCGA-EE-A183-06	D	2018-06-18	TCGA-EE-A183	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	48.0	M	Metastatic melanoma	0	0	371.0	1.0													0.34	2.13	
TCGA-EE-A184-06	B	2018-06-18	TCGA-EE-A184	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	72.0	M	Metastatic melanoma	I	IB	156.0	1.0			1309.0	1.0			2073.0		2073.0	1.0	1309.0	1.0	0.85	2.27	
TCGA-EE-A185-06	D	2018-06-18	TCGA-EE-A185	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	55.0	F	Metastatic melanoma	III	IIIC	131.0	1.0	65.0	1.0	85.0	1.0			151.0	1.0	151.0	1.0	85.0	1.0	0.93	1.86	
TCGA-EE-A20B-06	A	2018-06-18	TCGA-EE-A20B	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	66.0	F	Metastatic melanoma	II	II	1832.0	0.0	1832.0	0.0	4070.0	0.0			4070.0	0.0	4070.0	0.0	4070.0	0.0	0.75	1.72	
TCGA-EE-A20C-06	D	2018-06-18	TCGA-EE-A20C	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	59.0	M	Metastatic melanoma	0	0	132.0	1.0													0.93	3.55	
TCGA-EE-A20F-06	B	2018-06-18	TCGA-EE-A20F	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	53.0	M	Metastatic melanoma	I	I	482.0	0.0	482.0	0.0	2785.0	0.0			2785.0	0.0	2785.0	0.0	2785.0	0.0	0.7	1.89	
TCGA-EE-A20H-06	D	2018-06-18	TCGA-EE-A20H	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	56.0	M	Metastatic melanoma	I	I	280.0	1.0			4667.0	1.0			5118.0	1.0	5118.0	1.0	4667.0	1.0	0.95	3.3	
TCGA-EE-A20I-06	D	2018-06-18	TCGA-EE-A20I	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	79.0	M	Metastatic melanoma	IV	IV	36.0	1.0			53.0	1.0			412.0	1.0	412.0	1.0	53.0	1.0	0.78	1.76	
TCGA-EE-A29A-06	D	2018-06-18	TCGA-EE-A29A	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	68.0	M	Metastatic melanoma	III	IIIA	243.0	1.0			867.0	1.0			1927.0	1.0	1927.0	1.0	867.0	1.0	0.81	4.42	
TCGA-EE-A29B-06	D	2018-06-18	TCGA-EE-A29B	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	67.0	M	Metastatic melanoma	II	IIB	437.0	1.0			490.0	1.0			2588.0	1.0	2588.0	1.0	490.0	1.0	0.97	2.06	
TCGA-EE-A29C-06	D	2018-06-18	TCGA-EE-A29C	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	20.0	M	Metastatic melanoma	I	IB	2102.0	1.0			204.0	1.0			2402.0	1.0	2402.0	1.0	204.0	1.0	0.62	1.72	
TCGA-EE-A29D-06	D	2018-06-18	TCGA-EE-A29D	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	87.0	M	Metastatic melanoma	III	IIIC	339.0	1.0	339.0	0.0	425.0	0.0			425.0		425.0	1.0	425.0	1.0	0.95	3.68	
TCGA-EE-A29E-06	D	2018-06-18	TCGA-EE-A29E	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	54.0	M	Metastatic melanoma	III	IIIB	1910.0	0.0	1910.0	0.0	1940.0	0.0			1940.0	0.0	1940.0	0.0	1940.0	0.0	0.86	2.06	
TCGA-EE-A29G-06	C	2018-06-18	TCGA-EE-A29G	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	53.0	M	Metastatic melanoma	III	IIIA	260.0	1.0			726.0	1.0			2192.0	1.0	2192.0	1.0	726.0	1.0	0.21	2.86	
TCGA-EE-A29H-06	D	2018-06-18	TCGA-EE-A29H	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	59.0	F	Metastatic melanoma	I	IA	1121.0	0.0	386.0	1.0	1231.0	1.0			1966.0	0.0	1966.0	0.0	1231.0	1.0	0.86	1.92	
TCGA-EE-A29L-06	D	2018-06-18	TCGA-EE-A29L	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	78.0	M	Metastatic melanoma	III	IIIC	33.0	1.0	9.0	1.0	55.0	1.0			79.0		79.0	1.0	55.0	1.0	0.97	3.41	
TCGA-EE-A29M-06	B	2018-06-18	TCGA-EE-A29M	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	33.0	F	Metastatic melanoma	I	IB	1205.0	0.0	1205.0	0.0	1729.0	0.0			1729.0	0.0	1729.0	0.0	1729.0	0.0	0.58	1.86	
TCGA-EE-A29N-06	D	2018-06-18	TCGA-EE-A29N	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	78.0	M	Metastatic melanoma	I/II	I/II	289.0	1.0	201.0	1.0	478.0	1.0			566.0	1.0	566.0	1.0	478.0	1.0	0.41	1.99	
TCGA-EE-A29P-06	B	2018-06-18	TCGA-EE-A29P	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	73.0	F	Metastatic melanoma	II	IIC	366.0	0.0	318.0	1.0	1668.0	1.0			1716.0	0.0	1716.0	0.0	1668.0	1.0	0.43	3.41	
TCGA-EE-A29Q-06	D	2018-06-18	TCGA-EE-A29Q	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	70.0	F	Metastatic melanoma	II	IIB	1140.0	1.0	366.0	1.0	1256.0	1.0			2030.0	1.0	2030.0	1.0	1256.0	1.0	0.86	1.77	
TCGA-EE-A29R-06	C	2018-06-18	TCGA-EE-A29R	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	48.0	F	Metastatic melanoma	III	IIIC	269.0	0.0	255.0	1.0	426.0	1.0			440.0	0.0	440.0	0.0	426.0	1.0	0.98	2.58	
TCGA-EE-A29S-06	C	2018-06-18	TCGA-EE-A29S	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	79.0	M	Metastatic melanoma	II	IIA	467.0	1.0	21.0	1.0	1418.0	1.0			1864.0	1.0	1864.0	1.0	1418.0	1.0	0.69	1.91	
TCGA-EE-A29T-06	A	2018-06-18	TCGA-EE-A29T	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	51.0	F	Metastatic melanoma			926.0	0.0			7483.0	1.0			11252.0	0.0	11252.0	0.0	7483.0	1.0	0.4	3.36	
TCGA-EE-A29V-06	D	2018-06-18	TCGA-EE-A29V	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	85.0	M	Metastatic melanoma	III	IIIC	74.0	1.0			96.0	1.0			787.0	1.0	787.0	1.0	96.0	1.0	0.71	1.85	
TCGA-EE-A29W-06	D	2018-06-18	TCGA-EE-A29W	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	42.0	M	Metastatic melanoma	0	0	978.0	0.0													0.64	6.43	
TCGA-EE-A29X-06	B	2018-06-18	TCGA-EE-A29X	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	58.0	F	Metastatic melanoma	I	IB	246.0	1.0	92.0	1.0	391.0	1.0			545.0	1.0	545.0	1.0	391.0	1.0	0.74	1.61	
TCGA-EE-A2A0-06	A	2018-06-18	TCGA-EE-A2A0	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	77.0	F	Metastatic melanoma	II	IIA	344.0	1.0	167.0	1.0	1247.0	1.0			1424.0	1.0	1424.0	1.0	1247.0	1.0	0.39	1.91	
TCGA-EE-A2A1-06	A	2018-06-18	TCGA-EE-A2A1	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	46.0	M	Metastatic melanoma	I	IB	1894.0	0.0	1855.0	1.0	3488.0	1.0			3527.0	0.0	3527.0	0.0	3488.0	1.0	0.33	2.2	
TCGA-EE-A2A2-06	D	2018-06-18	TCGA-EE-A2A2	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	71.0	M	Metastatic melanoma	III	IIIC	1798.0	0.0	1798.0	0.0	1814.0	0.0			1814.0	0.0	1814.0	0.0	1814.0	0.0	0.83	1.93	
TCGA-EE-A2A5-06	D	2018-06-18	TCGA-EE-A2A5	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	43.0	M	Metastatic melanoma	I	IB	294.0	1.0	127.0	1.0	1028.0	1.0			1195.0	1.0	1195.0	1.0	1028.0	1.0	0.85	2.93	
TCGA-EE-A2A6-01	B	2018-06-18	TCGA-EE-A2A6	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1						1.0	43.0	M	Metastatic melanoma	I	IA	1105.0	0.0			1505.0	1.0			2620.0	0.0	2620.0	0.0	1505.0	1.0	0.55	2.19	
TCGA-EE-A2A6-06	B	2018-06-18	TCGA-EE-A2A6	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0		43.0	M	Metastatic melanoma	I	IA	1105.0	0.0			1505.0	1.0			2620.0	0.0	2620.0	0.0	1505.0	1.0			
TCGA-EE-A2GB-06	D	2018-06-18	TCGA-EE-A2GB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	51.0	M	Metastatic melanoma	III	IIIB	1555.0	0.0	1555.0	0.0	1803.0	0.0			1803.0	0.0	1803.0	0.0	1803.0	0.0	0.84	3.27	
TCGA-EE-A2GC-06	B	2018-06-18	TCGA-EE-A2GC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	82.0	M	Metastatic melanoma	II	IIB	1043.0	0.0	1043.0	0.0	2051.0	0.0			2051.0	0.0	2051.0	0.0	2051.0	0.0	0.6	3.48	
TCGA-EE-A2GD-06	C	2018-06-18	TCGA-EE-A2GD	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	58.0	F	Metastatic melanoma	II	IIB	1325.0	1.0			3689.0	1.0			10346.0	1.0	10346.0	1.0	3689.0	1.0	0.43	1.96	
TCGA-EE-A2GE-06	C	2018-06-18	TCGA-EE-A2GE	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	44.0	M	Metastatic melanoma	I	I	2213.0	0.0	2203.0	1.0	5276.0	1.0			5286.0	0.0	5286.0	0.0	5276.0	1.0	0.22	3.66	
TCGA-EE-A2GH-06	A	2018-06-18	TCGA-EE-A2GH	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	34.0	M	Metastatic melanoma	I	I	1807.0	0.0	1807.0	0.0	6699.0	0.0			6699.0	0.0	6699.0	0.0	6699.0	0.0	0.33	1.54	
TCGA-EE-A2GI-06	B	2018-06-18	TCGA-EE-A2GI	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	39.0	M	Metastatic melanoma	I	IA	915.0	0.0	915.0	0.0	1482.0	0.0			1482.0	0.0	1482.0	0.0	1482.0	0.0	0.54	3.26	
TCGA-EE-A2GJ-06	B	2018-06-18	TCGA-EE-A2GJ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	83.0	M	Metastatic melanoma	I	IA	1140.0	1.0			733.0	1.0			3266.0	1.0	3266.0	1.0	733.0	1.0	0.7	1.96	
TCGA-EE-A2GK-06	B	2018-06-18	TCGA-EE-A2GK	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	46.0	F	Metastatic melanoma	I	I	487.0	0.0	320.0	1.0	1498.0	1.0			1665.0	0.0	1665.0	0.0	1498.0	1.0	0.99	2.0	
TCGA-EE-A2GL-06	B	2018-06-18	TCGA-EE-A2GL	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	40.0	F	Metastatic melanoma	II	IIA	1081.0	0.0	987.0	1.0	2329.0	1.0			2423.0	0.0	2423.0	0.0	2329.0	1.0	0.26	2.09	
TCGA-EE-A2GM-06	D	2018-06-18	TCGA-EE-A2GM	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	70.0	F	Metastatic melanoma	II	IIC	861.0	0.0			1218.0	1.0			2296.0	0.0	2296.0	0.0	1218.0	1.0	0.86	3.24	
TCGA-EE-A2GN-06	D	2018-06-18	TCGA-EE-A2GN	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	67.0	M	Metastatic melanoma	II	IIA	1368.0	1.0	684.0	1.0	2422.0	1.0			3106.0	1.0	3106.0	1.0	2422.0	1.0	0.89	2.44	
TCGA-EE-A2GO-06	C	2018-06-18	TCGA-EE-A2GO	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	66.0	F	Metastatic melanoma	II	II	1694.0	0.0	53.0	1.0	2216.0	1.0			3857.0	0.0	3857.0	0.0	2216.0	1.0	0.93	3.0	
TCGA-EE-A2GP-06	C	2018-06-18	TCGA-EE-A2GP	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	80.0	M	Metastatic melanoma	III	IIIB	165.0	1.0			251.0	1.0			423.0	1.0	423.0	1.0	251.0	1.0	0.63	3.21	
TCGA-EE-A2GR-06	D	2018-06-18	TCGA-EE-A2GR	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	78.0	M	Metastatic melanoma	II	II	901.0	1.0	901.0	1.0	1301.0	1.0			1301.0	1.0	1301.0	1.0	1301.0	1.0	0.98	3.72	
TCGA-EE-A2GS-06	D	2018-06-18	TCGA-EE-A2GS	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	28.0	F	Metastatic melanoma	I	IB	1175.0	1.0	270.0	1.0	1565.0	1.0			2470.0	1.0	2470.0	1.0	1565.0	1.0	0.93	1.96	
TCGA-EE-A2GT-06	A	2018-06-18	TCGA-EE-A2GT	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	77.0	M	Metastatic melanoma	II	IIA	1064.0	0.0			281.0	1.0			1365.0	0.0	1365.0	0.0	281.0	1.0	0.43	2.01	
TCGA-EE-A2GU-06	B	2018-06-18	TCGA-EE-A2GU	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	65.0	F	Metastatic melanoma	I	IA	1105.0	0.0	1105.0	0.0	2884.0	0.0			2884.0	0.0	2884.0	0.0	2884.0	0.0	0.61	1.92	
TCGA-EE-A2M5-06	D	2018-06-18	TCGA-EE-A2M5	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	49.0	M	Metastatic melanoma	I	I	269.0	1.0	147.0	1.0	537.0	1.0			659.0	1.0	659.0	1.0	537.0	1.0	0.58	2.09	
TCGA-EE-A2M6-06	D	2018-06-18	TCGA-EE-A2M6	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	61.0	M	Metastatic melanoma	I	I	2989.0	0.0	2989.0	0.0	3932.0	0.0			3932.0	0.0	3932.0	0.0	3932.0	0.0	0.95	3.19	
TCGA-EE-A2M7-06	A	2018-06-18	TCGA-EE-A2M7	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	66.0	M	Metastatic melanoma	II	II	82.0	1.0	4.0	1.0	799.0	1.0			877.0	1.0	877.0	1.0	799.0	1.0	0.47	3.47	
TCGA-EE-A2M8-06	B	2018-06-18	TCGA-EE-A2M8	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	54.0	F	Metastatic melanoma	III	III	188.0	1.0	85.0	1.0	498.0	1.0			601.0	1.0	601.0	1.0	498.0	1.0	0.25	1.97	
TCGA-EE-A2MC-06	C	2018-06-18	TCGA-EE-A2MC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	73.0	M	Metastatic melanoma	I	I	1445.0	1.0	470.0	1.0	896.0	1.0			1871.0	0.0	1871.0	1.0	896.0	1.0	0.39	2.0	
TCGA-EE-A2MD-06	D	2018-06-18	TCGA-EE-A2MD	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	52.0	M	Metastatic melanoma	II	II	290.0	1.0	196.0	1.0	1344.0	1.0			1438.0	1.0	1438.0	1.0	1344.0	1.0	0.63	1.94	
TCGA-EE-A2ME-06	A	2018-06-18	TCGA-EE-A2ME	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	51.0	M	Metastatic melanoma	I	I	896.0	1.0	458.0	1.0	2703.0	1.0			3141.0	1.0	3141.0	1.0	2703.0	1.0	0.25	2.02	
TCGA-EE-A2MF-06	B	2018-06-18	TCGA-EE-A2MF	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	39.0	F	Metastatic melanoma	I	I	83.0	1.0			8071.0	1.0			8174.0	1.0	8174.0	1.0	8071.0	1.0	0.89	1.9	
TCGA-EE-A2MG-06	A	2018-06-18	TCGA-EE-A2MG	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	23.0	M	Metastatic melanoma	I	I	1346.0	1.0	792.0	1.0	2585.0	1.0			3139.0	1.0	3139.0	1.0	2585.0	1.0	0.31	1.72	
TCGA-EE-A2MH-06	B	2018-06-18	TCGA-EE-A2MH	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	66.0	M	Metastatic melanoma	III	III	242.0	1.0	166.0	1.0	440.0	1.0			516.0	1.0	516.0	1.0	440.0	1.0	0.43	2.0	
TCGA-EE-A2MI-06	C	2018-06-18	TCGA-EE-A2MI	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	43.0	M	Metastatic melanoma	II	IIB	443.0	1.0			2673.0	1.0			6225.0	1.0	6225.0	1.0	2673.0	1.0	0.66	2.06	
TCGA-EE-A2MJ-06	B	2018-06-18	TCGA-EE-A2MJ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	60.0	M	Metastatic melanoma	III	III	1929.0	1.0			396.0	1.0			2927.0	0.0	2927.0	1.0	396.0	1.0	0.35	1.78	
TCGA-EE-A2MK-06	B	2018-06-18	TCGA-EE-A2MK	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	18.0	F	Metastatic melanoma	III	III	4484.0	0.0	4484.0	0.0	5487.0	0.0			5487.0	0.0	5487.0	0.0	5487.0	0.0	0.77	2.67	
TCGA-EE-A2ML-06	B	2018-06-18	TCGA-EE-A2ML	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	35.0	M	Metastatic melanoma	II	II	3818.0	1.0	2211.0	1.0	4983.0	1.0			6590.0	1.0	6590.0	1.0	4983.0	1.0	0.62	2.12	
TCGA-EE-A2MM-06	D	2018-06-18	TCGA-EE-A2MM	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	63.0	F	Metastatic melanoma	I	I	1704.0	1.0			1357.0	1.0			5107.0	1.0	5107.0	1.0	1357.0	1.0	0.9	3.83	
TCGA-EE-A2MN-06	B	2018-06-18	TCGA-EE-A2MN	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	58.0	M	Metastatic melanoma	I	I	763.0	1.0	286.0	1.0	969.0	1.0			1446.0	1.0	1446.0	1.0	969.0	1.0	0.79	2.07	
TCGA-EE-A2MP-06	B	2018-06-18	TCGA-EE-A2MP	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	34.0	F	Metastatic melanoma	I	I	821.0	0.0			365.0	1.0			7563.0	0.0	7563.0	0.0	365.0	1.0	0.61	3.63	
TCGA-EE-A2MQ-06	D	2018-06-18	TCGA-EE-A2MQ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	70.0	F	Metastatic melanoma	III	IIIA	657.0	1.0	328.0	1.0	986.0	1.0			1315.0	1.0	1315.0	1.0	986.0	1.0	0.81	2.02	
TCGA-EE-A2MR-06	B	2018-06-18	TCGA-EE-A2MR	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	61.0	M	Metastatic melanoma	I	I	1840.0	0.0	888.0	1.0	3136.0	1.0			4088.0	0.0	4088.0	0.0	3136.0	1.0	0.22	2.29	
TCGA-EE-A2MS-06	D	2018-06-18	TCGA-EE-A2MS	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	72.0	M	Metastatic melanoma	II	II	1617.0	0.0			1883.0	1.0			4942.0	0.0	4942.0	0.0	1883.0	1.0	0.82	3.0	
TCGA-EE-A2MT-06	D	2018-06-18	TCGA-EE-A2MT	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	45.0	M	Metastatic melanoma	I	IB	1602.0	0.0	1602.0	0.0	2166.0	0.0			2166.0	0.0	2166.0	0.0	2166.0	0.0	0.88	2.04	
TCGA-EE-A2MU-06	B	2018-06-18	TCGA-EE-A2MU	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	71.0	M	Metastatic melanoma	I	IA	169.0	0.0	169.0	0.0	1620.0	0.0			1620.0	0.0	1620.0	0.0	1620.0	0.0	0.29	2.83	
TCGA-EE-A3AA-06	B	2018-06-18	TCGA-EE-A3AA	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	47.0	M	Metastatic melanoma	III	III	3781.0	0.0	3781.0	0.0	3781.0	0.0			3781.0	0.0	3781.0	0.0	3781.0	0.0	0.3	1.7	
TCGA-EE-A3AB-06	C	2018-06-18	TCGA-EE-A3AB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	30.0	M	Metastatic melanoma	III	III	3733.0	0.0	3733.0	0.0	3733.0	0.0			3733.0	0.0	3733.0	0.0	3733.0	0.0	0.51	3.73	
TCGA-EE-A3AC-06	B	2018-06-18	TCGA-EE-A3AC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	47.0	M	Metastatic melanoma	III	III	1948.0	0.0	1948.0	0.0	1948.0	0.0			1948.0	0.0	1948.0	0.0	1948.0	0.0	0.82	2.02	
TCGA-EE-A3AD-06	D	2018-06-18	TCGA-EE-A3AD	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	50.0	M	Metastatic melanoma	III	III	875.0	1.0	554.0	1.0	554.0	1.0			875.0	1.0	875.0	1.0	554.0	1.0	1.0	3.89	
TCGA-EE-A3AE-06	B	2018-06-18	TCGA-EE-A3AE	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	52.0	F	Metastatic melanoma	I	IA	1658.0	0.0	917.0	0.0	1658.0	0.0			1658.0	0.0	1658.0	0.0	1658.0	0.0	0.79	3.42	
TCGA-EE-A3AF-06	B	2018-06-18	TCGA-EE-A3AF	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	48.0	F	Metastatic melanoma	III	IIIC	420.0	1.0	201.0	1.0	201.0	1.0			420.0	1.0	420.0	1.0	201.0	1.0	0.78	1.92	
TCGA-EE-A3AG-06	D	2018-06-18	TCGA-EE-A3AG	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	25.0	M	Metastatic melanoma	III	III	1036.0	1.0			229.0	1.0			1265.0	1.0	1265.0	1.0	229.0	1.0	0.89	3.14	
TCGA-EE-A3AH-06	D	2018-06-18	TCGA-EE-A3AH	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	30.0	M	Metastatic melanoma	II	II	387.0	1.0			1981.0	1.0			4222.0	1.0	4222.0	1.0	1981.0	1.0	0.98	1.87	
TCGA-EE-A3J3-06	D	2018-06-18	TCGA-EE-A3J3	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	42.0	M	Metastatic melanoma	I	IB	98.0	1.0			4523.0	1.0			5237.0	1.0	5237.0	1.0	4523.0	1.0	0.63	3.62	
TCGA-EE-A3J4-06	B	2018-06-18	TCGA-EE-A3J4	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	72.0	M	Metastatic melanoma	II	II	697.0	1.0			1429.0	1.0			3869.0	1.0	3869.0	1.0	1429.0	1.0	0.91	2.06	
TCGA-EE-A3J5-06	B	2018-06-18	TCGA-EE-A3J5	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	71.0	M	Metastatic melanoma	III	III	657.0	1.0			467.0	1.0			1124.0	1.0	1124.0	1.0	467.0	1.0	0.73	1.84	
TCGA-EE-A3J7-06	D	2018-06-18	TCGA-EE-A3J7	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	43.0	M	Metastatic melanoma	I	I	657.0	0.0			1270.0	1.0			1949.0	0.0	1949.0	0.0	1270.0	1.0	0.89	2.53	
TCGA-EE-A3J8-06	D	2018-06-18	TCGA-EE-A3J8	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	59.0	M	Metastatic melanoma	III	IIIA	491.0	1.0	482.0	1.0	1035.0	1.0			1044.0	0.0	1044.0	1.0	1035.0	1.0	0.97	1.86	
TCGA-EE-A3JA-06	B	2018-06-18	TCGA-EE-A3JA	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	44.0	M	Metastatic melanoma	I	IB	676.0	1.0			539.0	1.0			1618.0	1.0	1618.0	1.0	539.0	1.0	0.75	2.54	
TCGA-EE-A3JB-06	C	2018-06-18	TCGA-EE-A3JB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	60.0	F	Metastatic melanoma	III	III	29.0	0.0			1434.0	1.0			6138.0	0.0	6138.0	0.0	1434.0	1.0	0.52	2.91	
TCGA-EE-A3JD-06	B	2018-06-18	TCGA-EE-A3JD	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	70.0	M	Metastatic melanoma	III	III	832.0	1.0	364.0	1.0	364.0	1.0			832.0	1.0	832.0	1.0	364.0	1.0	0.18	2.04	
TCGA-EE-A3JE-06	A	2018-06-18	TCGA-EE-A3JE	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	75.0	M	Metastatic melanoma	III	IIIB	560.0	0.0			194.0	1.0			1562.0	0.0	1562.0	0.0	194.0	1.0	0.26	1.83	
TCGA-EE-A3JH-06	A	2018-06-18	TCGA-EE-A3JH	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	54.0	M	Metastatic melanoma	I	IB	1414.0	0.0			537.0	1.0			4086.0	0.0	4086.0	0.0	537.0	1.0	0.21	2.91	
TCGA-EE-A3JI-06	D	2018-06-18	TCGA-EE-A3JI	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	48.0	M	Metastatic melanoma	I	I	1166.0	1.0			725.0	1.0			4648.0	1.0	4648.0	1.0	725.0	1.0	0.89	3.26	
TCGA-ER-A193-06	A	2018-06-18	TCGA-ER-A193	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	62.0	M	Metastatic melanoma	II	IIB	955.0	1.0	806.0	1.0	806.0	1.0			955.0	1.0	955.0	1.0	806.0	1.0	0.67	1.81	
TCGA-ER-A194-01	B	2018-06-18	TCGA-ER-A194	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	77.0	M	Metastatic melanoma			1276.0	1.0	1276.0	1.0	1354.0	1.0			1354.0	1.0	1354.0	1.0	1354.0	1.0	0.6	2.0	
TCGA-ER-A195-06	C	2018-06-18	TCGA-ER-A195	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	46.0	M	Metastatic melanoma			566.0	1.0	566.0	1.0	1078.0	1.0			1078.0	1.0	1078.0	1.0	1078.0	1.0	0.58	1.83	
TCGA-ER-A196-01	C	2018-06-18	TCGA-ER-A196	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	64.0	F	Metastatic melanoma	II	IIC	1785.0	0.0	1785.0	0.0	1785.0	0.0			1785.0	0.0	1785.0	0.0	1785.0	0.0	0.26	2.13	
TCGA-ER-A197-06	C	2018-06-18	TCGA-ER-A197	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	83.0	F	Metastatic melanoma	III	IIIB	394.0	1.0	80.0	1.0	110.0	1.0			424.0	1.0	424.0	1.0	110.0	1.0	0.31	3.17	
TCGA-ER-A198-06	D	2018-06-18	TCGA-ER-A198	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	45.0	M	Metastatic melanoma			1168.0	1.0			0.0	1.0			1544.0	1.0	1544.0	1.0	0.0	1.0	0.79	2.0	
TCGA-ER-A199-06	B	2018-06-18	TCGA-ER-A199	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	86.0	F	Metastatic melanoma	III	IIIC	174.0	1.0	14.0	1.0	119.0	1.0			279.0	1.0	279.0	1.0	119.0	1.0	0.42	1.39	
TCGA-ER-A19A-06	A	2018-06-18	TCGA-ER-A19A	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0		79.0	M	Metastatic melanoma	IV	IV	2324.0	0.0	1576.0	1.0	1617.0	1.0			2365.0	0.0	2365.0	0.0	1617.0	1.0			
TCGA-ER-A19C-06	C	2018-06-18	TCGA-ER-A19C	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	77.0	M	Metastatic melanoma	I	I	115.0	1.0	115.0	1.0	1487.0	1.0			1487.0	1.0	1487.0	1.0	1487.0	1.0	0.8	1.84	
TCGA-ER-A19D-06	C	2018-06-18	TCGA-ER-A19D	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	46.0	F	Metastatic melanoma	I	IB	107.0	1.0	81.0	1.0	357.0	1.0			383.0	1.0	383.0	1.0	357.0	1.0	0.77	2.89	
TCGA-ER-A19E-06	D	2018-06-18	TCGA-ER-A19E	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	36.0	F	Metastatic melanoma	I	IB	362.0	1.0	30.0	1.0	64.0	1.0			396.0	1.0	396.0	1.0	64.0	1.0	0.72	3.11	
TCGA-ER-A19F-06	D	2018-06-18	TCGA-ER-A19F	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	82.0	M	Metastatic melanoma			338.0	1.0	338.0	0.0	802.0	0.0			802.0	0.0	802.0	1.0	802.0	1.0	0.88	1.95	
TCGA-ER-A19G-06	B	2018-06-18	TCGA-ER-A19G	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	48.0	F	Metastatic melanoma			4480.0	0.0	4480.0	0.0	9188.0	0.0			9188.0	0.0	9188.0	0.0	9188.0	0.0	0.64	3.53	
TCGA-ER-A19H-06	D	2018-06-18	TCGA-ER-A19H	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	40.0	M	Metastatic melanoma			1061.0	1.0	1061.0	0.0	4634.0	0.0			4634.0	0.0	4634.0	1.0	4634.0	1.0	0.67	2.92	
TCGA-ER-A19J-06	C	2018-06-18	TCGA-ER-A19J	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	54.0	M	Metastatic melanoma	IV	IV	128.0	1.0	30.0	1.0	98.0	1.0			196.0	1.0	196.0	1.0	98.0	1.0	0.91	2.28	
TCGA-ER-A19K-01	D	2018-06-18	TCGA-ER-A19K	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	79.0	F	Metastatic melanoma	II	IIC	439.0	1.0	181.0	1.0	211.0	1.0			469.0	1.0	469.0	1.0	211.0	1.0	0.58	2.06	
TCGA-ER-A19L-06	C	2018-06-18	TCGA-ER-A19L	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	35.0	M	Metastatic melanoma			409.0	1.0	98.0	1.0	3689.0	1.0			4000.0	1.0	4000.0	1.0	3689.0	1.0	0.87	1.94	
TCGA-ER-A19M-06	B	2018-06-18	TCGA-ER-A19M	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	36.0	M	Metastatic melanoma	I	IB	870.0	1.0	165.0	1.0	1152.0	1.0			1857.0	1.0	1857.0	1.0	1152.0	1.0	0.51	2.46	
TCGA-ER-A19N-06	C	2018-06-18	TCGA-ER-A19N	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	47.0	M	Metastatic melanoma			1304.0	1.0			0.0	1.0			1341.0	0.0	1341.0	1.0	0.0	1.0	0.35	2.31	
TCGA-ER-A19O-06	A	2018-06-18	TCGA-ER-A19O	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	56.0	M	Metastatic melanoma	III	IIIB	308.0	1.0	260.0	1.0	308.0	1.0				1.0		1.0	308.0	1.0	0.49	2.08	
TCGA-ER-A19P-06	B	2018-06-18	TCGA-ER-A19P	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	47.0	F	Metastatic melanoma			1055.0	1.0	477.0	1.0	4352.0	1.0			4930.0	1.0	4930.0	1.0	4352.0	1.0	0.27	1.72	
TCGA-ER-A19Q-06	C	2018-06-18	TCGA-ER-A19Q	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	37.0	F	Metastatic melanoma			291.0	1.0	2.0	1.0	1259.0	1.0			1548.0	1.0	1548.0	1.0	1259.0	1.0	0.63	2.13	
TCGA-ER-A19S-06	B	2018-06-18	TCGA-ER-A19S	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	81.0	F	Metastatic melanoma			1469.0	0.0	1469.0	0.0	1505.0	0.0			1505.0	0.0	1505.0	0.0	1505.0	0.0	0.32	1.86	
TCGA-ER-A19W-06	B	2018-06-18	TCGA-ER-A19W	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	48.0	F	Metastatic melanoma			539.0	1.0	158.0	1.0	4126.0	1.0			4507.0	1.0	4507.0	1.0	4126.0	1.0	0.37	1.79	
TCGA-ER-A1A1-06	B	2018-06-18	TCGA-ER-A1A1	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	58.0	M	Metastatic melanoma	III	IIIC	3149.0	0.0	1924.0	1.0	1971.0	1.0			3196.0	0.0	3196.0	0.0	1971.0	1.0	0.2	2.0	
TCGA-ER-A2NC-06	C	2018-06-18	TCGA-ER-A2NC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	50.0	M	Metastatic melanoma	I	IB	359.0	1.0	183.0	1.0	1157.0	1.0			1333.0	1.0	1333.0	1.0	1157.0	1.0	0.73	2.27	
TCGA-ER-A3ET-06	C	2018-06-18	TCGA-ER-A3ET	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	64.0	F	Metastatic melanoma	III	IIIA	586.0	1.0	192.0	1.0	2435.0	1.0			2829.0	1.0	2829.0	1.0	2435.0	1.0	0.6	2.46	
TCGA-ER-A3PL-06	C	2018-06-18	TCGA-ER-A3PL	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	30.0	M	Metastatic melanoma	IV	IV	52.0	0.0			945.0	1.0			1010.0	0.0	1010.0	0.0	945.0	1.0	0.77	5.19	
TCGA-ER-A42H-01	D	2018-06-18	TCGA-ER-A42H	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	76.0	M	Metastatic melanoma			312.0	1.0	145.0	1.0	259.0	1.0			426.0	1.0	426.0	1.0	259.0	1.0	0.94	4.36	
TCGA-ER-A42K-06	C	2018-06-18	TCGA-ER-A42K	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	40.0	F	Metastatic melanoma	III	IIIC	359.0	1.0	171.0	1.0	206.0	1.0			394.0	1.0	394.0	1.0	206.0	1.0	0.85	2.0	
TCGA-ER-A42L-06	A	2018-06-18	TCGA-ER-A42L	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	49.0	M	Metastatic melanoma	II	II	1144.0	0.0	423.0	1.0	3812.0	1.0			4533.0	0.0	4533.0	0.0	3812.0	1.0	0.11	5.01	
TCGA-FR-A2OS-01	C	2018-06-18	TCGA-FR-A2OS	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	49.0	F	Metastatic melanoma	II	IIC	368.0	1.0	283.0	1.0	283.0	1.0			368.0	1.0	368.0	1.0	283.0	1.0	0.65	4.07	
TCGA-FR-A3R1-01	B	2018-06-18	TCGA-FR-A3R1	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	69.0	M	Metastatic melanoma	II	IIC	685.0	0.0	678.0	1.0	678.0	1.0			685.0	0.0	685.0	0.0	678.0	1.0	0.75	2.07	
TCGA-FR-A3YN-06	B	2018-06-18	TCGA-FR-A3YN	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	44.0	M	Metastatic melanoma	I	IB	560.0	0.0	560.0	0.0	2828.0	0.0			2828.0	0.0	2828.0	0.0	2828.0	0.0	0.73	3.6	
TCGA-FR-A3YO-06	C	2018-06-18	TCGA-FR-A3YO	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0		F	Metastatic melanoma	I/II	I/II						0.0				0.0		0.0		0.0	0.41	3.64	
TCGA-FR-A44A-06	B	2018-06-18	TCGA-FR-A44A	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	29.0	F	Metastatic melanoma	II	II	2608.0	0.0	2608.0	0.0	5299.0	0.0			5299.0	0.0	5299.0	0.0	5299.0	0.0	0.27	3.45	
TCGA-FR-A69P-06	D	2018-06-18	TCGA-FR-A69P	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	34.0	F	Metastatic melanoma	III	IIIC	478.0	0.0	274.0	1.0	274.0	1.0			478.0	0.0	478.0	0.0	274.0	1.0	0.77	3.09	
TCGA-FR-A726-01	D	2018-06-18	TCGA-FR-A726	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	90.0	M	Metastatic melanoma	II	IIC	274.0	1.0	242.0	1.0	273.0	1.0			305.0	1.0	305.0	1.0	273.0	1.0	0.7	2.05	
TCGA-FR-A728-01	A	2018-06-18	TCGA-FR-A728	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	54.0	F	Metastatic melanoma	III	IIIB	567.0	0.0	48.0	1.0	64.0	1.0			583.0	0.0	583.0	0.0	64.0	1.0	0.29	3.32	
TCGA-FR-A729-06	B	2018-06-18	TCGA-FR-A729	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	38.0	F	Metastatic melanoma	I	I	530.0	0.0	113.0	1.0	6299.0	1.0			6716.0	0.0	6716.0	0.0	6299.0	1.0	0.44	3.52	
TCGA-FR-A7U8-06	D	2018-06-18	TCGA-FR-A7U8	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	50.0	M	Metastatic melanoma	III	IIIC	495.0	0.0	215.0	1.0	567.0	1.0			847.0	0.0	847.0	0.0	567.0	1.0	0.89	1.92	
TCGA-FR-A7U9-06	C	2018-06-18	TCGA-FR-A7U9	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	63.0	F	Metastatic melanoma	III	IIIC	521.0	0.0	45.0	1.0	95.0	1.0			571.0	0.0	571.0	0.0	95.0	1.0	0.28	4.18	
TCGA-FR-A7UA-06	B	2018-06-18	TCGA-FR-A7UA	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	65.0	F	Metastatic melanoma	I	IB	404.0	0.0	404.0	0.0	1164.0	0.0			1164.0	0.0	1164.0	0.0	1164.0	0.0	0.17	1.9	
TCGA-FR-A8YC-06	A	2018-06-18	TCGA-FR-A8YC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	78.0	M	Metastatic melanoma	II	IIB	67.0	1.0	67.0	1.0	1059.0	1.0			1059.0	1.0	1059.0	1.0	1059.0	1.0	0.8	3.32	
TCGA-FR-A8YD-06	D	2018-06-18	TCGA-FR-A8YD	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	56.0	F	Metastatic melanoma	II	IIC	350.0	1.0	350.0	1.0	1103.0	1.0			1103.0	1.0	1103.0	1.0	1103.0	1.0	0.79	2.4	
TCGA-FR-A8YE-06	A	2018-06-18	TCGA-FR-A8YE	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	41.0	M	Metastatic melanoma	I	IA	405.0	0.0	405.0	0.0	3176.0	0.0			3176.0	0.0	3176.0	0.0	3176.0	0.0	0.21	2.08	
TCGA-FS-A1YW-06	A	2018-06-18	TCGA-FS-A1YW	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	52.0	M	Metastatic melanoma	I	IB	1961.0	1.0	1961.0	1.0	6598.0	1.0			6598.0	1.0	6598.0	1.0	6598.0	1.0	0.87	1.93	
TCGA-FS-A1YX-06	C	2018-06-18	TCGA-FS-A1YX	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	39.0	F	Metastatic melanoma	I	I	105.0	1.0	105.0	1.0	1478.0	1.0			1478.0	1.0	1478.0	1.0	1478.0	1.0	0.76	1.63	
TCGA-FS-A1YY-06	C	2018-06-18	TCGA-FS-A1YY	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	55.0	F	Metastatic melanoma	II	IIA	335.0	1.0	159.0	1.0	6777.0	1.0			6953.0	1.0	6953.0	1.0	6777.0	1.0	0.75	1.84	
TCGA-FS-A1Z0-06	B	2018-06-18	TCGA-FS-A1Z0	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	32.0	F	Metastatic melanoma	I	IA	724.0	1.0	63.0	1.0	5503.0	1.0			6164.0	1.0	6164.0	1.0	5503.0	1.0	0.73	1.94	
TCGA-FS-A1Z3-06	D	2018-06-18	TCGA-FS-A1Z3	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	72.0	F	Metastatic melanoma	IV	IV	433.0	1.0	73.0	1.0	276.0	1.0			636.0	1.0	636.0	1.0	276.0	1.0	0.87	2.05	
TCGA-FS-A1Z4-06	D	2018-06-18	TCGA-FS-A1Z4	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	62.0	M	Metastatic melanoma	I	I	472.0	1.0	472.0	1.0	854.0	1.0			854.0	1.0	854.0	1.0	854.0	1.0	0.3	1.6	
TCGA-FS-A1Z7-06	C	2018-06-18	TCGA-FS-A1Z7	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	19.0	M	Metastatic melanoma	III	IIIC	223.0	1.0	122.0	1.0	136.0	1.0			237.0	1.0	237.0	1.0	136.0	1.0	0.61	2.12	
TCGA-FS-A1ZA-06	C	2018-06-18	TCGA-FS-A1ZA	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	45.0	F	Metastatic melanoma	III	IIIB	222.0	1.0	42.0	1.0	663.0	1.0			843.0	1.0	843.0	1.0	663.0	1.0	0.69	3.6	
TCGA-FS-A1ZB-06	C	2018-06-18	TCGA-FS-A1ZB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	57.0	M	Metastatic melanoma	II	II	103.0	1.0	78.0	1.0	1461.0	1.0			1486.0	1.0	1486.0	1.0	1461.0	1.0	0.52	1.85	
TCGA-FS-A1ZC-06	D	2018-06-18	TCGA-FS-A1ZC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	51.0	M	Metastatic melanoma	I/II	I/II	620.0	1.0	84.0	1.0	10334.0	1.0			10870.0	1.0	10870.0	1.0	10334.0	1.0	0.89	3.09	
TCGA-FS-A1ZD-06	D	2018-06-18	TCGA-FS-A1ZD	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	63.0	M	Metastatic melanoma	II	IIA	250.0	1.0	119.0	1.0	1497.0	1.0			1628.0	1.0	1628.0	1.0	1497.0	1.0	0.87	3.38	
TCGA-FS-A1ZE-06	D	2018-06-18	TCGA-FS-A1ZE	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	40.0	M	Metastatic melanoma	II	IIC	782.0	1.0	130.0	1.0	761.0	1.0			1413.0	1.0	1413.0	1.0	761.0	1.0	0.98	2.07	
TCGA-FS-A1ZF-06	D	2018-06-18	TCGA-FS-A1ZF	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	78.0	F	Metastatic melanoma	II	IIC	337.0	1.0	337.0	1.0	470.0	1.0			470.0	1.0	470.0	1.0	470.0	1.0	0.93	1.91	
TCGA-FS-A1ZG-06	B	2018-06-18	TCGA-FS-A1ZG	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	60.0	F	Metastatic melanoma	III	IIIC	218.0	1.0	63.0	1.0	140.0	1.0			295.0	1.0	295.0	1.0	140.0	1.0	1.0	1.97	
TCGA-FS-A1ZH-06	A	2018-06-18	TCGA-FS-A1ZH	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	71.0	F	Metastatic melanoma	IV	IV	939.0	1.0	520.0	1.0	577.0	1.0			996.0	1.0	996.0	1.0	577.0	1.0	0.47	3.63	
TCGA-FS-A1ZJ-06	D	2018-06-18	TCGA-FS-A1ZJ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	75.0	F	Metastatic melanoma	I	I	393.0	1.0	177.0	1.0	1225.0	1.0			1441.0	1.0	1441.0	1.0	1225.0	1.0	0.94	1.95	
TCGA-FS-A1ZK-06	D	2018-06-18	TCGA-FS-A1ZK	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	68.0	M	Metastatic melanoma	II	II	392.0	1.0	31.0	1.0	367.0	1.0			728.0	1.0	728.0	1.0	367.0	1.0	0.9	2.8	
TCGA-FS-A1ZM-06	A	2018-06-18	TCGA-FS-A1ZM	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	74.0	M	Metastatic melanoma	III	III	1441.0	0.0	1441.0	0.0	3080.0	0.0			3080.0	0.0	3080.0	0.0	3080.0	0.0	0.99	2.53	
TCGA-FS-A1ZN-01	C	2018-06-18	TCGA-FS-A1ZN	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	43.0	M	Metastatic melanoma	III	IIIA	730.0	1.0	361.0	1.0	361.0	1.0			730.0	1.0	730.0	1.0	361.0	1.0	0.95	1.98	
TCGA-FS-A1ZP-06	A	2018-06-18	TCGA-FS-A1ZP	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	52.0	M	Metastatic melanoma	II	II	1584.0	1.0	1584.0	1.0	2273.0	1.0			2273.0	1.0	2273.0	1.0	2273.0	1.0	0.81	2.27	
TCGA-FS-A1ZQ-06	D	2018-06-18	TCGA-FS-A1ZQ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	31.0	M	Metastatic melanoma	I/II	I/II	263.0	1.0	141.0	1.0	3940.0	1.0			4062.0	1.0	4062.0	1.0	3940.0	1.0	0.78	1.69	
TCGA-FS-A1ZR-06	D	2018-06-18	TCGA-FS-A1ZR	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	36.0	M	Metastatic melanoma	II	II	268.0	1.0	73.0	1.0	152.0	1.0			347.0	1.0	347.0	1.0	152.0	1.0	0.81	1.95	
TCGA-FS-A1ZS-06	C	2018-06-18	TCGA-FS-A1ZS	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	54.0	M	Metastatic melanoma	I	I	1495.0	0.0			2861.0	1.0			4526.0	0.0	4526.0	0.0	2861.0	1.0	0.75	4.06	
TCGA-FS-A1ZT-06	B	2018-06-18	TCGA-FS-A1ZT	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	55.0	M	Metastatic melanoma	III	III	1236.0	0.0	1236.0	0.0	1617.0	0.0			1617.0	0.0	1617.0	0.0	1617.0	0.0	0.69	2.06	
TCGA-FS-A1ZU-06	D	2018-06-18	TCGA-FS-A1ZU	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	70.0	F	Metastatic melanoma	II	IIC	264.0	1.0	135.0	1.0	679.0	1.0			808.0	1.0	808.0	1.0	679.0	1.0	0.95	3.45	
TCGA-FS-A1ZW-06	B	2018-06-18	TCGA-FS-A1ZW	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	65.0	M	Metastatic melanoma	III	IIIB	833.0	0.0	833.0	0.0	1505.0	0.0			1505.0	0.0	1505.0	0.0	1505.0	0.0	0.62	1.8	
TCGA-FS-A1ZY-06	D	2018-06-18	TCGA-FS-A1ZY	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	71.0	M	Metastatic melanoma	II	IIB	25.0	1.0	25.0	1.0	824.0	1.0			824.0	1.0	824.0	1.0	824.0	1.0	0.97	3.28	
TCGA-FS-A1ZZ-06	D	2018-06-18	TCGA-FS-A1ZZ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	54.0	F	Metastatic melanoma	II	IIB	159.0	1.0	159.0	1.0	822.0	1.0			822.0	1.0	822.0	1.0	822.0	1.0	1.0	2.05	
TCGA-FS-A4F0-06	D	2018-06-18	TCGA-FS-A4F0	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	67.0	F	Metastatic melanoma	II	IIB	1638.0	0.0	143.0	1.0	872.0	1.0			2367.0	0.0	2367.0	0.0	872.0	1.0	0.98	1.92	
TCGA-FS-A4F2-06	C	2018-06-18	TCGA-FS-A4F2	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded		1.0		0.0	1.0	46.0	F	Metastatic melanoma	II	IIC	98.0	1.0	98.0	1.0	1525.0	1.0			1525.0	1.0	1525.0	1.0	1525.0	1.0	0.76	3.31	
TCGA-FS-A4F4-06	D	2018-06-18	TCGA-FS-A4F4	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	64.0	M	Metastatic melanoma	II	II	224.0	1.0	224.0	1.0	2028.0	1.0			2028.0	1.0	2028.0	1.0	2028.0	1.0	0.79	1.91	
TCGA-FS-A4F5-06	C	2018-06-18	TCGA-FS-A4F5	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	77.0	F	Metastatic melanoma	I	IB	874.0	1.0	874.0	1.0	874.0	1.0			874.0	1.0	874.0	1.0	874.0	1.0	0.89	3.28	
TCGA-FS-A4F8-06	A	2018-06-18	TCGA-FS-A4F8	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	52.0	M	Metastatic melanoma	I	I	432.0	1.0	432.0	1.0	5318.0	1.0			5318.0	1.0	5318.0	1.0	5318.0	1.0	0.37	1.44	
TCGA-FS-A4F9-06	D	2018-06-18	TCGA-FS-A4F9	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	80.0	M	Metastatic melanoma	III	IIIC	985.0	0.0	326.0	1.0	376.0	1.0			1035.0	0.0	1035.0	0.0	376.0	1.0	0.93	1.88	
TCGA-FS-A4FB-06	D	2018-06-18	TCGA-FS-A4FB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	46.0	F	Metastatic melanoma	III	III	182.0	1.0	182.0	1.0	813.0	1.0			813.0	1.0	813.0	1.0	813.0	1.0	0.94	1.85	
TCGA-FS-A4FC-06	C	2018-06-18	TCGA-FS-A4FC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	75.0	F	Metastatic melanoma	II	IIA	346.0	1.0	346.0	1.0	1655.0	1.0			1655.0	1.0	1655.0	1.0	1655.0	1.0	0.59	1.97	
TCGA-FS-A4FD-06	D	2018-06-18	TCGA-FS-A4FD	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	39.0	M	Metastatic melanoma	III	IIIC	154.0	1.0			2010.0	1.0			2454.0	1.0	2454.0	1.0	2010.0	1.0	0.82	2.21	
TCGA-FW-A3I3-06	D	2018-06-18	TCGA-FW-A3I3	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	59.0	F	Metastatic melanoma	IV	IV	531.0	0.0	531.0	0.0	531.0	0.0			531.0	0.0	531.0	0.0	531.0	0.0	0.89	3.26	
TCGA-FW-A3R5-06	D	2018-06-18	TCGA-FW-A3R5	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0		68.0	M	Metastatic melanoma	III	III	457.0	0.0	457.0	0.0	1124.0	0.0			1124.0	0.0	1124.0	0.0	1124.0	0.0			
TCGA-FW-A3TU-06	B	2018-06-18	TCGA-FW-A3TU	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	72.0	F	Metastatic melanoma			249.0	1.0	249.0	1.0	1691.0	1.0			1691.0	1.0	1691.0	1.0	1691.0	1.0	0.84	1.85	
TCGA-FW-A3TV-06	A	2018-06-18	TCGA-FW-A3TV	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	57.0	F	Metastatic melanoma	III	IIIB	411.0	0.0	139.0	1.0	139.0	1.0			411.0	0.0	411.0	0.0	139.0	1.0	0.64	1.82	
TCGA-FW-A5DX-01	D	2018-06-18	TCGA-FW-A5DX	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	71.0	M	Metastatic melanoma	III	IIIC	629.0	0.0	629.0	0.0	640.0	0.0			640.0	0.0	640.0	0.0	640.0	0.0	0.86	5.07	
TCGA-FW-A5DY-06	B	2018-06-18	TCGA-FW-A5DY	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	48.0	F	Metastatic melanoma	III	III	527.0	0.0	527.0	0.0	587.0	0.0			587.0	0.0	587.0	0.0	587.0	0.0	0.16	2.06	
TCGA-GF-A2C7-01	D	2018-06-18	TCGA-GF-A2C7	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	48.0	M	Metastatic melanoma	II	IIC	21.0	0.0			21.0	0.0			21.0	0.0	21.0	0.0	21.0	0.0	0.85	2.09	
TCGA-GF-A3OT-06	C	2018-06-18	TCGA-GF-A3OT	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	58.0	F	Metastatic melanoma	III	IIIC	301.0	0.0	248.0	1.0	248.0	1.0			301.0	0.0	301.0	0.0	248.0	1.0	0.47	2.07	
TCGA-GF-A4EO-06	B	2018-06-18	TCGA-GF-A4EO	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	74.0	F	Metastatic melanoma	III	IIIC	591.0	0.0	591.0	0.0	591.0	0.0			591.0	0.0	591.0	0.0	591.0	0.0	0.22	3.16	
TCGA-GF-A6C8-06	D	2018-06-18	TCGA-GF-A6C8	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	62.0	F	Metastatic melanoma	II	IIB	26.0	0.0	26.0	0.0	62.0	0.0			62.0	0.0	62.0	0.0	62.0	0.0	0.67	1.78	
TCGA-GF-A6C9-06	B	2018-06-18	TCGA-GF-A6C9	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	78.0	M	Metastatic melanoma	III	IIIB	476.0	0.0	476.0	0.0	480.0	0.0			480.0	0.0	480.0	0.0	480.0	0.0	0.32	1.88	
TCGA-GF-A769-01	D	2018-06-18	TCGA-GF-A769	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	39.0	M	Metastatic melanoma	II	IIC	1070.0	1.0	1070.0	1.0	1070.0	1.0			1070.0	1.0	1070.0	1.0	1070.0	1.0	0.86	2.3	
TCGA-GN-A262-06	D	2018-06-18	TCGA-GN-A262	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	47.0	F	Metastatic melanoma			1347.0	0.0			2908.0	1.0			4255.0	0.0	4255.0	0.0	2908.0	1.0	1.0	1.71	
TCGA-GN-A263-01	D	2018-06-18	TCGA-GN-A263	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	24.0	M	Metastatic melanoma	IV	IV	467.0	1.0	39.0	1.0	39.0	1.0			467.0	1.0	467.0	1.0	39.0	1.0	0.53	1.91	
TCGA-GN-A264-06	C	2018-06-18	TCGA-GN-A264	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	60.0	M	Metastatic melanoma			953.0	1.0	587.0	1.0	3221.0	1.0			3587.0	1.0	3587.0	1.0	3221.0	1.0	0.83	3.01	
TCGA-GN-A265-06	C	2018-06-18	TCGA-GN-A265	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	53.0	M	Metastatic melanoma			2948.0	0.0	99.0	1.0	99.0	1.0			2948.0	0.0	2948.0	0.0	99.0	1.0	0.17	2.47	
TCGA-GN-A266-06	C	2018-06-18	TCGA-GN-A266	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	45.0	M	Metastatic melanoma			308.0	1.0	109.0	1.0	109.0	1.0			308.0	1.0	308.0	1.0	109.0	1.0	0.54	3.06	
TCGA-GN-A267-06	B	2018-06-18	TCGA-GN-A267	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	38.0	M	Metastatic melanoma	III	IIIA	494.0	1.0			456.0	1.0			1960.0	1.0	1960.0	1.0	456.0	1.0	0.74	2.02	
TCGA-GN-A268-06	D	2018-06-18	TCGA-GN-A268	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	83.0	F	Metastatic melanoma	II	IIB	469.0	1.0			908.0	1.0			1910.0	1.0	1910.0	1.0	908.0	1.0	0.99	1.86	
TCGA-GN-A26A-06	C	2018-06-18	TCGA-GN-A26A	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	63.0	F	Metastatic melanoma	III	IIIA	370.0	1.0	132.0	1.0	750.0	1.0			988.0	1.0	988.0	1.0	750.0	1.0	0.48	3.24	
TCGA-GN-A26C-01	A	2018-06-18	TCGA-GN-A26C	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	77.0	M	Metastatic melanoma	III	IIIC	730.0	1.0	502.0	1.0	593.0	1.0			821.0	1.0	821.0	1.0	593.0	1.0	0.38	2.54	
TCGA-GN-A26D-06	D	2018-06-18	TCGA-GN-A26D	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	72.0	F	Metastatic melanoma	II	IIC	703.0	1.0			622.0	1.0			1460.0	1.0	1460.0	1.0	622.0	1.0	0.78	3.19	
TCGA-GN-A4U3-06	D	2018-06-18	TCGA-GN-A4U3	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	30.0	M	Metastatic melanoma	III	III	1478.0	0.0	44.0	1.0	2274.0	1.0			3708.0	0.0	3708.0	0.0	2274.0	1.0	0.85	3.47	
TCGA-GN-A4U4-06	D	2018-06-18	TCGA-GN-A4U4	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	73.0	M	Metastatic melanoma	II	IIA	1155.0	0.0	175.0	1.0	217.0	1.0			1197.0	0.0	1197.0	0.0	217.0	1.0	0.76	2.02	
TCGA-GN-A4U5-01	B	2018-06-18	TCGA-GN-A4U5	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	61.0	F	Metastatic melanoma	I	IB	1156.0	0.0	1156.0	0.0	1156.0	0.0			1156.0	0.0	1156.0	0.0	1156.0	0.0	0.46	2.01	
TCGA-GN-A4U7-06	D	2018-06-18	TCGA-GN-A4U7	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	56.0	F	Metastatic melanoma	III	IIIC	169.0	1.0	35.0	1.0	183.0	1.0			317.0	1.0	317.0	1.0	183.0	1.0	0.9	1.99	
TCGA-GN-A4U8-06	B	2018-06-18	TCGA-GN-A4U8	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	51.0	M	Metastatic melanoma			437.0	0.0	437.0	0.0	1487.0	0.0			1487.0	0.0	1487.0	0.0	1487.0	0.0	0.52	2.01	
TCGA-GN-A4U8-11			TCGA-GN-A4U8	Normal	SKCM	TCGA-SKCM	1	0	0	FF_PolyA_NStranded		1.0		0.0		51.0	M	Metastatic melanoma			437.0	0.0	437.0	0.0	1487.0	0.0			1487.0	0.0	1487.0	0.0	1487.0	0.0			
TCGA-GN-A4U9-06	D	2018-06-18	TCGA-GN-A4U9	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	71.0	M	Metastatic melanoma	III	IIIC	613.0	1.0	91.0	1.0	151.0	1.0			673.0	1.0	673.0	1.0	151.0	1.0	0.87	3.13	
TCGA-GN-A8LK-06	D	2018-06-18	TCGA-GN-A8LK	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	70.0	M	Metastatic melanoma	I	IB	441.0	1.0			436.0	1.0			1524.0	1.0	1524.0	1.0	436.0	1.0	0.95	3.53	
TCGA-GN-A8LL-06	D	2018-06-18	TCGA-GN-A8LL	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	68.0	F	Metastatic melanoma	II	IIC	441.0	1.0	441.0	1.0	650.0	1.0			650.0	1.0	650.0	1.0	650.0	1.0	0.93	2.04	
TCGA-GN-A8LN-01	C	2018-06-18	TCGA-GN-A8LN	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	68.0	M	Metastatic melanoma	II	IIC	748.0	0.0	162.0	1.0	186.0	1.0			772.0	0.0	772.0	0.0	186.0	1.0	0.86	3.4	
TCGA-HR-A2OG-01	C	2018-06-18	TCGA-HR-A2OG	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1						1.0	50.0	F	Metastatic melanoma			7.0	0.0	7.0	0.0	7.0	0.0			7.0	0.0	7.0	0.0	7.0	0.0	0.41	3.93	
TCGA-HR-A2OG-06	C	2018-06-18	TCGA-HR-A2OG	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0		50.0	F	Metastatic melanoma			7.0	0.0	7.0	0.0	7.0	0.0			7.0	0.0	7.0	0.0	7.0	0.0			
TCGA-HR-A2OH-06	B	2018-06-18	TCGA-HR-A2OH	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0		46.0	F	Metastatic melanoma	III	IIIB	481.0	1.0	481.0	1.0	2004.0	1.0			2004.0	1.0	2004.0	1.0	2004.0	1.0			
TCGA-HR-A2OH-01	B	2018-06-18	TCGA-HR-A2OH	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1						1.0	46.0	F	Metastatic melanoma	III	IIIB	481.0	1.0	481.0	1.0	2004.0	1.0			2004.0	1.0	2004.0	1.0	2004.0	1.0	0.43	2.06	
TCGA-HR-A5NC-01	C	2018-06-18	TCGA-HR-A5NC	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	90.0	F	Metastatic melanoma			1000.0	0.0	154.0	1.0	154.0	1.0			1000.0	0.0	1000.0	0.0	154.0	1.0	0.78	1.75	
TCGA-IH-A3EA-01	C	2018-06-18	TCGA-IH-A3EA	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	61.0	M	Metastatic melanoma	II	IIC	383.0	0.0	173.0	1.0	314.0	1.0			524.0	0.0	524.0	0.0	314.0	1.0	0.75	2.06	
TCGA-LH-A9QB-06	C	2018-06-18	TCGA-LH-A9QB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	24.0	F	Metastatic melanoma			370.0	0.0	370.0	0.0	11217.0	0.0			11217.0	0.0	11217.0	0.0	11217.0	0.0	0.95	1.91	
TCGA-OD-A75X-06	D	2018-06-18	TCGA-OD-A75X	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	49.0	M	Metastatic melanoma			431.0	1.0	357.0	1.0	8987.0	1.0			9061.0	1.0	9061.0	1.0	8987.0	1.0	0.83	3.69	
TCGA-QB-A6FS-06	B	2018-06-18	TCGA-QB-A6FS	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	49.0	M	Metastatic melanoma	III	IIIC	193.0	0.0	36.0	1.0	63.0	1.0			220.0	0.0	220.0	0.0	63.0	1.0	0.44	2.21	
TCGA-QB-AA9O-06	B	2018-06-18	TCGA-QB-AA9O	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	73.0	M	Metastatic melanoma	III	IIIC	549.0	1.0	549.0	1.0	549.0	1.0			549.0	1.0	549.0	1.0	549.0	1.0	0.62	3.45	
TCGA-RP-A690-06	A	2018-06-18	TCGA-RP-A690	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	66.0	F	Metastatic melanoma			6.0	0.0	6.0	0.0	6.0	0.0			6.0	0.0	6.0	0.0	6.0	0.0	0.96	2.02	
TCGA-RP-A693-06	A	2018-06-18	TCGA-RP-A693	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	77.0	M	Metastatic melanoma	IV	IV	10.0	0.0	10.0	0.0	10.0	0.0			10.0	0.0	10.0	0.0	10.0	0.0	0.32	3.74	
TCGA-RP-A694-06	D	2018-06-18	TCGA-RP-A694	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	71.0	M	Metastatic melanoma	IV	IV	21.0	0.0	21.0	0.0	21.0	0.0			21.0	0.0	21.0	0.0	21.0	0.0	0.65	2.05	
TCGA-RP-A695-06	D	2018-06-18	TCGA-RP-A695	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0		M	Metastatic melanoma	IV	IV						0.0				0.0		0.0		0.0	0.63	3.57	
TCGA-W3-A825-06	C	2018-06-18	TCGA-W3-A825	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	60.0	F	Metastatic melanoma	II	II	273.0	1.0	273.0	1.0	1917.0	1.0			1917.0	1.0	1917.0	1.0	1917.0	1.0	0.69	3.09	
TCGA-W3-A828-06	C	2018-06-18	TCGA-W3-A828	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	66.0	M	Metastatic melanoma	II	II	1826.0	1.0	1826.0	0.0	3683.0	0.0			3683.0		3683.0	1.0	3683.0	1.0	0.66	2.02	
TCGA-W3-AA1O-06	D	2018-06-18	TCGA-W3-AA1O	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	85.0	M	Metastatic melanoma	III	III	91.0	1.0	91.0	1.0	122.0	1.0			122.0	1.0	122.0	1.0	122.0	1.0	0.77	2.48	
TCGA-W3-AA1Q-06	B	2018-06-18	TCGA-W3-AA1Q	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	57.0	M	Metastatic melanoma	III	III	1219.0	1.0	184.0	1.0	1066.0	1.0			2101.0	1.0	2101.0	1.0	1066.0	1.0	0.71	2.12	
TCGA-W3-AA1R-06	D	2018-06-18	TCGA-W3-AA1R	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	71.0	M	Metastatic melanoma	II	II	2618.0	1.0	276.0	1.0	1037.0	1.0			3379.0	1.0	3379.0	1.0	1037.0	1.0	0.85	1.92	
TCGA-W3-AA1V-06	C	2018-06-18	TCGA-W3-AA1V	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	63.0	M	Metastatic melanoma	II	II	334.0	1.0	273.0	1.0	1219.0	1.0			1280.0	1.0	1280.0	1.0	1219.0	1.0	0.73	2.7	
TCGA-W3-AA1W-06	B	2018-06-18	TCGA-W3-AA1W	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	64.0	M	Metastatic melanoma	II	II	5632.0	0.0			335.0	1.0			6666.0	0.0	6666.0	0.0	335.0	1.0	0.37	2.23	
TCGA-W3-AA21-06	B	2018-06-18	TCGA-W3-AA21	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	26.0	M	Metastatic melanoma	I	I	2160.0	1.0	1917.0	1.0	2952.0	1.0			3195.0	1.0	3195.0	1.0	2952.0	1.0	0.89	2.28	
TCGA-WE-A8JZ-06	D	2018-06-18	TCGA-WE-A8JZ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	70.0	M	Metastatic melanoma	III	IIIB	360.0	0.0	360.0	0.0	731.0	0.0			731.0	0.0	731.0	0.0	731.0	0.0	0.84	3.33	
TCGA-WE-A8K1-06	B	2018-06-18	TCGA-WE-A8K1	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	74.0	M	Metastatic melanoma	III	IIIC	486.0	0.0	486.0	0.0	1492.0	0.0			1492.0	0.0	1492.0	0.0	1492.0	0.0	0.44	2.09	
TCGA-WE-A8K4-01	B	2018-06-18	TCGA-WE-A8K4	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	85.0	M	Metastatic melanoma	II	IIB	614.0	0.0	614.0	0.0	614.0	0.0			614.0	0.0	614.0	0.0	614.0	0.0	0.52	1.88	
TCGA-WE-A8K5-06	D	2018-06-18	TCGA-WE-A8K5	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	65.0	M	Metastatic melanoma	IV	IV	403.0	1.0	41.0	1.0	1498.0	1.0			1860.0	1.0	1860.0	1.0	1498.0	1.0	0.72	3.98	
TCGA-WE-A8K6-06	C	2018-06-18	TCGA-WE-A8K6	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	79.0	M	Metastatic melanoma	III	IIIB	500.0	0.0	210.0	1.0	256.0	1.0			546.0	0.0	546.0	0.0	256.0	1.0	0.8	3.32	
TCGA-WE-A8ZM-06	D	2018-06-18	TCGA-WE-A8ZM	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	70.0	M	Metastatic melanoma	III	IIIB	904.0	0.0			646.0	1.0			3082.0	0.0	3082.0	0.0	646.0	1.0	0.85	3.79	
TCGA-WE-A8ZN-06	A	2018-06-18	TCGA-WE-A8ZN	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	57.0	M	Metastatic melanoma	II	IIB	702.0	0.0	357.0	1.0	1449.0	1.0			1794.0	0.0	1794.0	0.0	1449.0	1.0	0.51	2.06	
TCGA-WE-A8ZO-06	B	2018-06-18	TCGA-WE-A8ZO	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	73.0	F	Metastatic melanoma	III	IIIB	737.0	0.0			1371.0	1.0			2145.0	0.0	2145.0	0.0	1371.0	1.0	0.81	1.99	
TCGA-WE-A8ZQ-06	D	2018-06-18	TCGA-WE-A8ZQ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	48.0	M	Metastatic melanoma	II	IIA	444.0	0.0	278.0	1.0	1757.0	1.0			1923.0	0.0	1923.0	0.0	1757.0	1.0	0.94	3.28	
TCGA-WE-A8ZR-06	D	2018-06-18	TCGA-WE-A8ZR	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded		1.0		1.0		49.0	M	Metastatic melanoma	III	IIIC	250.0	1.0	102.0	1.0	126.0	1.0			274.0	1.0	274.0	1.0	126.0	1.0			
TCGA-WE-A8ZT-06	D	2018-06-18	TCGA-WE-A8ZT	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	25.0	F	Metastatic melanoma	IV	IV	349.0	0.0	59.0	1.0	69.0	1.0			359.0	0.0	359.0	0.0	69.0	1.0	0.81	2.03	
TCGA-WE-A8ZX-06	B	2018-06-18	TCGA-WE-A8ZX	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	45.0	M	Metastatic melanoma	III	IIIB	1063.0	0.0	300.0	1.0	326.0	1.0			1089.0	0.0	1089.0	0.0	326.0	1.0	0.62	3.24	
TCGA-WE-A8ZY-06	D	2018-06-18	TCGA-WE-A8ZY	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	62.0	M	Metastatic melanoma	II	IIA	339.0	1.0	222.0	1.0	1389.0	1.0			1506.0	1.0	1506.0	1.0	1389.0	1.0	0.81	2.86	
TCGA-WE-AA9Y-06	C	2018-06-18	TCGA-WE-AA9Y	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	37.0	M	Metastatic melanoma	III	IIIC	336.0	0.0	336.0	0.0	370.0	0.0			370.0	0.0	370.0	0.0	370.0	0.0	0.28	1.88	
TCGA-WE-AAA0-06	B	2018-06-18	TCGA-WE-AAA0	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	47.0	M	Metastatic melanoma	I	IA	918.0	0.0	339.0	1.0	650.0	1.0			1229.0	0.0	1229.0	0.0	650.0	1.0	0.61	2.08	
TCGA-WE-AAA3-06	C	2018-06-18	TCGA-WE-AAA3	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	84.0	F	Metastatic melanoma	III	IIIC	395.0	0.0	395.0	0.0	651.0	0.0			651.0	0.0	651.0	0.0	651.0	0.0	0.49	3.3	
TCGA-WE-AAA4-06	A	2018-06-18	TCGA-WE-AAA4	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	56.0	F	Metastatic melanoma	III	IIIC	666.0	0.0	429.0	1.0	523.0	1.0			760.0	0.0	760.0	0.0	523.0	1.0	0.36	1.88	
TCGA-XV-A9VZ-01	D	2018-06-18	TCGA-XV-A9VZ	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	90.0	F	Metastatic melanoma	II	II	11.0	0.0	11.0	0.0	11.0	0.0			11.0	0.0	11.0	0.0	11.0	0.0	0.67	1.99	
TCGA-XV-A9W2-01	D	2018-06-18	TCGA-XV-A9W2	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	81.0	M	Metastatic melanoma	I	I	417.0	0.0	417.0	0.0	417.0	0.0			417.0	0.0	417.0	0.0	417.0	0.0	0.54	2.0	
TCGA-XV-A9W5-01	D	2018-06-18	TCGA-XV-A9W5	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	51.0	M	Metastatic melanoma	I/II	I/II	392.0	0.0	392.0	0.0	392.0	0.0			392.0	0.0	392.0	0.0	392.0	0.0	0.72	2.02	
TCGA-XV-AAZV-01	A	2018-06-18	TCGA-XV-AAZV	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	56.0	F	Metastatic melanoma	II	II	412.0	0.0	412.0	0.0	412.0	0.0			412.0	0.0	412.0	0.0	412.0	0.0	0.53	1.53	
TCGA-XV-AAZW-01	D	2018-06-18	TCGA-XV-AAZW	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	62.0	F	Metastatic melanoma	II	II	393.0	1.0	393.0	1.0	393.0	1.0			393.0	1.0	393.0	1.0	393.0	1.0	0.84	1.9	
TCGA-XV-AAZY-01	D	2018-06-18	TCGA-XV-AAZY	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	76.0	F	Metastatic melanoma	III	IIIC	405.0	0.0	405.0	0.0	405.0	0.0			405.0	0.0	405.0	0.0	405.0	0.0	0.46	1.91	
TCGA-XV-AB01-06	A	2018-06-18	TCGA-XV-AB01	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded		1.0		0.0		54.0	F	Metastatic melanoma	II	II	403.0	0.0	403.0	0.0	403.0	0.0			403.0	0.0	403.0	0.0	403.0	0.0			
TCGA-YD-A89C-06	D	2018-06-18	TCGA-YD-A89C	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	43.0	F	Metastatic melanoma	I	IA	8.0	0.0	8.0	0.0	210.0	0.0			210.0	0.0	210.0	0.0	210.0	0.0	0.78	2.31	
TCGA-YD-A9TA-06	C	2018-06-18	TCGA-YD-A9TA	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	75.0	M	Metastatic melanoma			570.0	0.0	570.0	0.0	1496.0	0.0			1496.0	0.0	1496.0	0.0	1496.0	0.0	0.71	3.1	
TCGA-YD-A9TB-06	C	2018-06-18	TCGA-YD-A9TB	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0		F	Metastatic melanoma								0.0				0.0		0.0		0.0	0.6	3.98	
TCGA-YG-AA3N-01	B	2018-06-18	TCGA-YG-AA3N	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	67.0	M	Metastatic melanoma	II	IIC	306.0	0.0	306.0	0.0	306.0	0.0			306.0	0.0	306.0	0.0	306.0	0.0	0.66	2.05	
TCGA-YG-AA3O-06	D	2018-06-18	TCGA-YG-AA3O	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	62.0	M	Metastatic melanoma			246.0	1.0	91.0	1.0	999.0	1.0			1154.0	1.0	1154.0	1.0	999.0	1.0	0.62	3.78	
TCGA-YG-AA3P-06	D	2018-06-18	TCGA-YG-AA3P	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	63.0	F	Metastatic melanoma	II	IIB	143.0	0.0	143.0	0.0	439.0	0.0			439.0	0.0	439.0	0.0	439.0	0.0	0.97	3.73	
TCGA-Z2-A8RT-06	B	2018-06-18	TCGA-Z2-A8RT	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	42.0	F	Metastatic melanoma	II	IIB	370.0	0.0	370.0	0.0	839.0	0.0			839.0	0.0	839.0	0.0	839.0	0.0	0.83	1.82	
TCGA-Z2-AA3S-06	B	2018-06-18	TCGA-Z2-AA3S	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	58.0	M	Metastatic melanoma	I	IA	322.0	0.0	99.0	1.0	2727.0	1.0			2950.0	0.0	2950.0	0.0	2727.0	1.0	0.91	1.89	
TCGA-Z2-AA3V-06	B	2018-06-18	TCGA-Z2-AA3V	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	57.0	F	Metastatic melanoma	I	IA	311.0	0.0	311.0	0.0	486.0	0.0			486.0	0.0	486.0	0.0	486.0	0.0	0.45	1.98	
TCGA-D3-A1QA-07			TCGA-D3-A1QA	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	0	FF_PolyA_NStranded		1.0				55.0	M		I	IB					1393.0	1.0			2765.0	0.0	2765.0	0.0	1393.0	1.0			
TCGA-D3-A1QA-06			TCGA-D3-A1QA	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0	0.0	1.0	55.0	M		I	IB					1393.0	1.0			2765.0	0.0	2765.0	0.0	1393.0	1.0	0.91	2.09	
TCGA-D3-A51H-06			TCGA-D3-A51H	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1		FF_WES		1.0	1.0	1.0	60.0	M		III	IIIC					838.0	1.0			1714.0	0.0	1714.0	0.0	838.0	1.0	0.1	2.01	
TCGA-D9-A4Z2-01			TCGA-D9-A4Z2	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1		FF_WES		1.0	1.0	1.0	50.0	M		III	IIIC					80.0	1.0			190.0	1.0	190.0	1.0	80.0	1.0	0.89	1.99	
TCGA-ER-A2NF-01			TCGA-ER-A2NF	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	0	FF_PolyA_NStranded	FF_WES	1.0	1.0	1.0	1.0	53.0	M		III	IIIB					230.0	1.0			877.0	1.0	877.0	1.0	230.0	1.0	0.58	2.2	
TCGA-ER-A2NF-06			TCGA-ER-A2NF	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1	FF_PolyA_NStranded	FF_WES	1.0	1.0		1.0	53.0	M		III	IIIB					230.0	1.0			877.0	1.0	877.0	1.0	230.0	1.0	0.86	2.2	
TCGA-GN-A269-01			TCGA-GN-A269	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1		FF_WES		1.0		1.0	70.0	M		III	IIIC					170.0	1.0			170.0	1.0	170.0	1.0	170.0	1.0	0.37	2.13	
TCGA-W3-A824-06			TCGA-W3-A824	TCGA-SKCM	SKCM	TCGA-SKCM	1	1	1		FF_WES		1.0	1.0	1.0	63.0	M		I	I					2406.0	1.0			6940.0	0.0	6940.0	0.0	2406.0	1.0	0.75	2.1	
